
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Addressing the challenge of obesity in primary care: a review of effective interventions and implementation strategies - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532F8F8AF23053052F8F00033D1AA5.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="diametsyn">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372397/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Diabetology &amp; Metabolic Syndrome">
<meta name="citation_title" content="Addressing the challenge of obesity in primary care: a review of effective interventions and implementation strategies">
<meta name="citation_author" content="Mahan Khani">
<meta name="citation_author_institution" content="Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Reza Afsahi">
<meta name="citation_author_institution" content="Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Ali Ebrahimi Nasab">
<meta name="citation_author_institution" content="Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Sina Hemmati Bi’aragh">
<meta name="citation_author_institution" content="Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Kimia Rasouli">
<meta name="citation_author_institution" content="Tabriz University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Mehdi Hassani Ahangar">
<meta name="citation_author_institution" content="Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Abbas Sarvari Soltani">
<meta name="citation_author_institution" content="Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Ramtin Pourahmad">
<meta name="citation_author_institution" content="Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author_institution" content="Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="17">
<meta name="citation_firstpage" content="351">
<meta name="citation_doi" content="10.1186/s13098-025-01925-z">
<meta name="citation_pmid" content="40846976">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372397/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372397/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372397/pdf/13098_2025_Article_1925.pdf">
<meta name="description" content="Obesity is a worldwide health epidemic that significantly raises morbidity and mortality by means of related comorbidities including diabetes and cardiovascular diseases. By means of effective interventions including behavioral therapies, ...">
<meta name="og:title" content="Addressing the challenge of obesity in primary care: a review of effective interventions and implementation strategies">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Obesity is a worldwide health epidemic that significantly raises morbidity and mortality by means of related comorbidities including diabetes and cardiovascular diseases. By means of effective interventions including behavioral therapies, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372397/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372397">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13098-025-01925-z"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13098_2025_Article_1925.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372397%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372397/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372397/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372397/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-diametsyn.png" alt="Diabetology &amp; Metabolic Syndrome logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Diabetology &amp; Metabolic Syndrome" title="Link to Diabetology &amp; Metabolic Syndrome" shape="default" href="https://dmsjournal.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Diabetol Metab Syndr</button></div>. 2025 Aug 22;17:351. doi: <a href="https://doi.org/10.1186/s13098-025-01925-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13098-025-01925-z</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Diabetol%20Metab%20Syndr%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetol%20Metab%20Syndr%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Diabetol%20Metab%20Syndr%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Diabetol%20Metab%20Syndr%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Addressing the challenge of obesity in primary care: a review of effective interventions and implementation strategies</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khani%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Mahan Khani</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Mahan Khani</span></h3>
<div class="p">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khani%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mahan Khani</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Afsahi%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Reza Afsahi</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Reza Afsahi</span></h3>
<div class="p">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Afsahi%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Reza Afsahi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nasab%20AE%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ali Ebrahimi Nasab</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ali Ebrahimi Nasab</span></h3>
<div class="p">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nasab%20AE%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Ebrahimi Nasab</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bi%E2%80%99aragh%20SH%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Sina Hemmati Bi’aragh</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Sina Hemmati Bi’aragh</span></h3>
<div class="p">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bi%E2%80%99aragh%20SH%22%5BAuthor%5D" class="usa-link"><span class="name western">Sina Hemmati Bi’aragh</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rasouli%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Kimia Rasouli</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Kimia Rasouli</span></h3>
<div class="p">
<sup>2</sup>Tabriz University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rasouli%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kimia Rasouli</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahangar%20MH%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mehdi Hassani Ahangar</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mehdi Hassani Ahangar</span></h3>
<div class="p">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahangar%20MH%22%5BAuthor%5D" class="usa-link"><span class="name western">Mehdi Hassani Ahangar</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soltani%20AS%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Abbas Sarvari Soltani</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Abbas Sarvari Soltani</span></h3>
<div class="p">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soltani%20AS%22%5BAuthor%5D" class="usa-link"><span class="name western">Abbas Sarvari Soltani</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pourahmad%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Ramtin Pourahmad</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Ramtin Pourahmad</span></h3>
<div class="p">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">
<sup>3</sup>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pourahmad%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ramtin Pourahmad</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Tehran University of Medical Sciences, Tehran, Iran </div>
<div id="Aff2">
<sup>2</sup>Tabriz University of Medical Sciences, Tehran, Iran </div>
<div id="Aff3">
<sup>3</sup>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jul 3; Accepted 2025 Aug 15; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372397  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846976/" class="usa-link">40846976</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Obesity is a worldwide health epidemic that significantly raises morbidity and mortality by means of related comorbidities including diabetes and cardiovascular diseases. By means of effective interventions including behavioral therapies, comprehensive lifestyle modifications, and an increasing armamentarium of pharmacological agents capable of appreciable weight loss, primary care physicians are especially positioned to contribute significantly to the management of obesity. This review summarizes the most recent studies on behavioral interventions (such as cognitive behavioral therapy and motivational interviewing), pharmacological treatment options (including recently approved and emerging agents), and lifestyle changes (such diet and physical activity) in order to manage obesity in primary care environments. It also addresses the several challenges this field faces—including weight stigma and systematic barriers—as well as future directions for research and fair treatment of patients. At last, it emphasizes evidence-based approaches for putting these interventions into use to maximize patient results. More study is needed to guarantee that everyone has fair access to high-quality obesity treatment, understand the long-term consequences of new treatments, and enhance intervention procedures.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13098-025-01925-z.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Obesity, Weight loss, Pharmacology, Behavioral therapy, Primary care, Implementation, GLP-1, GIP</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Obesity is a complex, chronic, relapsing, multifactorial disease that is recognized as a global pandemic and is typified by excessive fat accumulation that compromise health [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Globally, the prevalence of obesity has sharply increased. More than 890 million adults worldwide—or 16% of the adult population—were obese in 2022; this number has more than doubled since 1990. Over one billion people worldwide, including 880 million adults and 159 million children and adolescents, were living with obesity in 2022, according to data from the NCD Risk Factor Collaboration (NCD-RisC), which was published in 2024 after evaluating 3,663 population-representative studies [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The situation is similarly alarming in the United States, where the age-adjusted prevalence of adult obesity was 40.3% from August 2021 to August 2023, and the rate of severe obesity was 9.4% [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. According to projections, a third of children and adolescents (746 million) and 60% of adults (3.8 billion) worldwide will be overweight or obese by 2050 if immediate policy reform and action are not taken. There is a serious risk to public health from this increasing trend, which is seen in almost every nation [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Beyond its profound health implications, obesity carries a substantial economic burden. Globally, this was estimated at 2.19% of the global GDP in 2019, with projections indicating these costs could exceed US$ 4.32 trillion annually by 2035 if current trends persist. These figures encompass direct medical expenses for treating obesity and its associated comorbidities, as well as indirect costs stemming from lost productivity and reduced workforce participation [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par3">Obesity significantly contributes to global morbidity and mortality, increasing the risk of numerous chronic diseases, including cardiovascular diseases (CVD), type 2 diabetes mellitus (T2DM), various cancers (such as endometrial, breast, ovarian, prostate, liver, gallbladder, kidney, and colon), and musculoskeletal disorders like osteoarthritis [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Effective obesity management within primary care settings is therefore crucial for preventing associated morbidity and mortality.</p>
<p id="Par4">Serving as the first and usually most frequent point of contact for people seeking health care, primary care environments are essential in addressing the obesity epidemic. Primary care doctors (PCPs) are positioned to deliver continuous, thorough treatment including early identification, prevention, evidence-based counseling, starting of medical treatment, and coordination of multidisciplinary care. Given the chronic character of obesity, long-term management and support depend on the constant care model that underlies primary healthcare. Effective patient-provider communication and treatment adherence can be hampered by PCPs’ many obstacles, which include time restrictions, insufficient training in obesity management, lack of reimbursement for comprehensive obesity care, and the widespread problem of weight bias and stigma. By aggregating present evidence-based behavioral and pharmacological treatments for obesity management in primary care, investigating ways to overcome implementation obstacles, and advocating fair, patient-centered care, this review meets a critical need [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>].</p>
<p id="Par5">This review specifically looks at lifestyle changes, behavioral interventions (Cognitive Behavioral Therapy and Motivational Interviewing), FDA-approved as well as new pharmacological treatment choices. Moreover, this review addresses the difficulties in primary care environments and talks on ways to maximize patient outcomes and support fair treatment. This review intends to guide health promotion practice by stressing successful intervention strategies and implementation issues for primary care providers, so providing an overview of present evidence and challenges. It also points up important areas for next studies and policy development to help control obesity and hence lower the load of this chronic condition.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Foundational clinical guidance from global and national health organizations</h2>
<p id="Par6">While numerous national and specialty-specific bodies provide guidance on obesity management, the recommendations from the World Health Organization (WHO) and the American Diabetes Association (ADA) offer a foundational framework that is particularly relevant for primary care. These guidelines not only define the scope of the problem but also shape the principles of modern, patient-centered obesity care.</p>
<section id="Sec3"><h3 class="pmc_sec_title">World health organization (WHO) perspective</h3>
<p id="Par7">The WHO provides a global perspective on the obesity epidemic, defining it through standardized Body Mass Index (BMI) thresholds: for adults, a BMI ≥ 25 kg/m2 is classified as overweight, and a BMI ≥ 30 kg/m<sup>2</sup> is classified as obesity. For children and adolescents, age- and sex-specific growth reference charts are used. The WHO frames obesity as a largely preventable and manageable disease, advocating for a life-course approach that begins before conception and continues throughout life.</p>
<p id="Par8">For individuals, the WHO’s recommendations center on fundamental lifestyle principles including limiting energy intake from total fats and sugars, increasing consumption of fruits, vegetables, legumes, whole grains, and nuts, and engaging in regular physical activity. For children, specific guidance includes promoting exclusive breastfeeding, limiting screen time, and reducing the intake of sugar-sweetened beverages and energy-dense foods.</p>
<p id="Par9">Crucially, the WHO framework emphasizes that individual-level interventions, while necessary, are insufficient to tackle the obesity pandemic and calls for a multi-pronged, systemic effort that addresses the “obesogenic environment.” This approach highlights the need for parallel actions at the community and policy levels in order to achieve true progress. The WHO calls on the food industry to play a significant role by reducing the fat, sugar, and salt content of processed foods, making healthy choices inexpensive and accessible, and limiting the marketing of unhealthy foods, particularly to children. At the governmental level, the WHO advocates for structural and regulatory actions to create healthy food environments and integrate obesity management into primary healthcare systems.</p>
<p id="Par10">WHO Acceleration plan to stop obesity, adopted by member states in 2022, which aims to generate political impetus, support country-level implementation, and strengthen accountability for tackling the crisis. This socio-ecological model is vital for PCPs, as it frames their clinical efforts within a larger public health context, acknowledging that patient success is influenced by factors far beyond the clinic walls [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>].</p></section><section id="Sec4"><h3 class="pmc_sec_title">American diabetes association (ADA) 2025 standards of care</h3>
<p id="Par11">The ADA’s annual “Standards of Care in Diabetes” provides some of the most current and influential guidance on weight management, particularly for the vast number of patients with or at risk for type 2 diabetes. The 2025 update solidifies a paradigm shift toward a more holistic and long-term approach to obesity care. A central theme of the 2025 guidelines is the emphasis on a person-centered approach. The ADA advocates for using person-first, inclusive language (e.g., “person with obesity” instead of “obese person”) and for actively detecting and mitigating weight stigma and bias in clinical settings. This recommendation acknowledges that stigmatizing experiences are a significant barrier to care, leading to patient avoidance and reduced treatment adherence. For treatment, the ADA recommends a weight loss goal of at least 3–7% through lifestyle interventions, with more ambitious targets for achieving specific complication-related benefits. The guidelines now firmly position obesity as a chronic, relapsing disease, analogous to hypertension or diabetes itself. This reframing has profound implications, most notably in the guidance for pharmacotherapy. The ADA recommends that anti-obesity medications (AOMs), when used, should be continued long-term to maintain weight loss and health benefits, explicitly warning against the weight regain and worsening of cardiometabolic markers that often follow discontinuation. This reframes AOMs from short-term aids to long-term, disease-modifying agents [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p></section></section><section id="Sec5"><h2 class="pmc_sec_title">Behavioral interventions</h2>
<p id="Par12">For decades, behavioral approaches—which evolved from basic behavior modification strategies to more advanced psychotherapeutic interventions like Cognitive Behavioral Therapy (CBT) and Motivational Interviewing (MI)—have been the pillar of obesity management. By addressing underlying beliefs, emotions, and motivations, these therapies seek to enable sustainable changes in eating and physical activity behaviors. Though long-term maintenance is still difficult, multicomponent behavioral interventions—often including self-monitoring, dietary and physical activity counseling, and problem-solving—can produce 5–10% weight loss (Table <a href="#Tab1" class="usa-link">1</a>) [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Key behavioral intervention strategies for obesity management in primary care</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Intervention Strategy</th>
<th align="left" colspan="1" rowspan="1">Core Components</th>
<th align="left" colspan="1" rowspan="1">Primary Goal(s)</th>
<th align="left" colspan="1" rowspan="1">Key Considerations for Primary Care</th>
<th align="left" colspan="1" rowspan="1">Representative Citations</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Lifestyle Modification</td>
<td align="left" colspan="1" rowspan="1">Calorie-restricted diet (e.g., 500–750 kcal deficit); Increased physical activity (e.g., ≥ 150 min/week moderate)</td>
<td align="left" colspan="1" rowspan="1">Achieve negative energy balance for weight loss; Improve metabolic health; Maintain weight loss long-term</td>
<td align="left" colspan="1" rowspan="1">Individualize diet based on preference &amp; adherence; Combine aerobic &amp; resistance exercise; Emphasize sustainability.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cognitive Behavioral Therapy (CBT)</td>
<td align="left" colspan="1" rowspan="1">Self-monitoring; Goal setting; Stimulus control; Cognitive restructuring; Problem-solving; Relapse prevention</td>
<td align="left" colspan="1" rowspan="1">Identify &amp; modify maladaptive thoughts/behaviors related to eating &amp; activity; Improve coping skills</td>
<td align="left" colspan="1" rowspan="1">Effective for BED; May require referral to trained therapist; Can be adapted for brief primary care interventions; Focus on skill-building.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>–<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Motivational Interviewing (MI)</td>
<td align="left" colspan="1" rowspan="1">Express empathy; Develop discrepancy; Roll with resistance; Support self-efficacy; Open-ended questions; Affirmations</td>
<td align="left" colspan="1" rowspan="1">Enhance intrinsic motivation for change; Resolve ambivalence; Facilitate patient commitment to goals</td>
<td align="left" colspan="1" rowspan="1">Patient-centered; Avoids confrontation; Useful for ambivalent patients; Requires training for effective delivery; Often best combined with other behavioral strategies.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>–<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Structured Behavioral Programs (often multicomponent)</td>
<td align="left" colspan="1" rowspan="1">Regular contact (individual/group); Education on nutrition/activity; Behavior change techniques; Social support</td>
<td align="left" colspan="1" rowspan="1">Achieve &amp; maintain clinically significant weight loss (typically 5–10%); Improve health behaviors</td>
<td align="left" colspan="1" rowspan="1">Can be delivered by various health professionals; Digital platforms offer scalable options; Intensity &amp; duration matter for effectiveness; Address barriers to adherence.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>, <a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p16">
<p>
<sub>BED = Binge Eating Disorder</sub>
</p>
<p>
<sub>These strategies are often most effective when combined and tailored to the individual patient</sub>
</p>
</div></div></section><section id="Sec6"><h3 class="pmc_sec_title">Lifestyle modifications</h3>
<p id="Par13">Achieving a negative energy balance through lifestyle modifications remains the cornerstone of managing obesity. Insulin sensitivity, lipid profiles, blood pressure, and energy metabolism are all impacted by these therapies [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Dietary interventions aim to reduce caloric intake, typically by 500–750 kcal/day from baseline, in order to induce weight loss [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Numerous dietary regimens have shown promise. The Mediterranean diet is recommended due to its short-term weight loss benefits and possible long-term cardiovascular benefits. Nuts, whole grains, fruits, vegetables, and unsaturated fats are all abundant in it. Low-carb diets (limiting carbohydrate intake to less than 130 g/day or even less than 50 g/day in very-low-carbohydrate approaches) can also help people lose weight and improve their glycemic control, especially those with type 2 diabetes. However, cardiovascular safety and long-term adherence—especially with animal-based versions—need to be carefully considered. Even though they are common, intermittent fasting and time-restricted eating (like the 5:2 diet or alternate-day fasting) haven’t been shown to consistently result in more weight loss than continuous calorie restriction when total caloric intake is equal. But for some, they might offer a different approach. Other options include low-fat diets (less than 30% energy from fat) and high-protein diets (which can maintain lean mass and improve satiety during weight loss). Ultimately, the most effective diet is one that is nutritionally adequate, long-term sustainable, and supports overall health [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The fundamental principles of any given diet are to prioritize whole, unprocessed foods, reduce intake of refined sugars and saturated fats (especially sugary drinks), and ensure adequate fiber intake. The effectiveness of dietary interventions can be impacted by a number of other modifiable risk factors, such as frequent consumption of ultra-processed foods, sleep deprivation, and food insecurity, highlighting the necessity of a comprehensive approach [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p>
<p id="Par14">Physical activity is a crucial addition to dietary changes for initial weight loss in order to sustain weight loss and lower obesity-related comorbidities. Current guidelines, such as those from the ACC/AHA and ESC, generally recommend at least 150 min of moderate-intensity aerobic activity (like brisk walking) or 75 min of vigorous-intensity aerobic activity per week for health benefits. Maintaining weight loss and preventing weight gain may require up to 200–300 min of moderate-intensity exercise per week [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Combining resistance and aerobic exercise often yields the best results. Aerobic exercise significantly enhances cardiorespiratory fitness, while resistance training—two to three sessions per week focused on major muscle groups—helps build and maintain muscle mass, which can be metabolically advantageous, particularly during calorie restriction. Resistance training has also been independently associated with a lower risk of obesity. Using tools like pedometers or activity trackers, as well as integrating physical activity into daily routines (e.g., active commuting, taking the stairs), can increase adherence and overall activity levels. Exercise regimens for obese older adults should be tailored to their individual preferences, realistic goals, and any physical limitations they may have, such as sarcopenic obesity [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. A systematic review and meta-analysis showed that aerobic, resistance and combined aerobic-resistance training methods all significantly improve cardiorespiratory fitness in overweight and obese adults. Resistance training, while less effective than aerobic exercise for cardiovascular fitness, does build muscle strength [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. In addition, a prospective cohort study reported that resistance exercise independently lowered the risk of obesity; the lowest risk was seen when guidelines for both resistance and aerobic exercise were met. Such findings suggest that different modes of exercise play complementary roles in managing obesity [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Other practical strategies involve integrating physical activity into a person’s daily routine, like walking to work, group exercise, or simply wearing an accelerometer that acts as a device for tracking activity.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Behavioral therapy</h3>
<p id="Par15">Behavioral approaches, which range from basic behavior modification to more advanced methods like motivational interviewing and cognitive-behavioral therapy, have been the cornerstone of managing obesity for the past 60 years. Their main goals are to change eating and exercise habits in order to bring about long-lasting lifestyle improvements [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>].</p>
<section id="Sec8"><h4 class="pmc_sec_title">Cognitive-behavioral therapy (CBT)</h4>
<p id="Par16">Cognitive Behavioral Therapy (CBT) is recognized as the best-established, first-line treatment for Binge Eating Disorder (BED), a condition commonly associated with obesity. CBT demonstrates robust effectiveness in reducing the frequency of binge-eating episodes and improving eating disorder psychopathology, with remission rates of 40–60% that are well-sustained at 12-month follow-ups. However, a crucial clinical consideration is that while CBT is highly effective for the eating disorder itself, it generally fails to produce significant weight loss on its own. Studies have shown that achieving remission from binge-eating is significantly associated with greater subsequent weight loss, suggesting that addressing the underlying eating disorder behavior is a critical step in long-term weight management for this patient population [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>–<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. New research also suggests that other therapeutic approaches, like dialectical behavior therapy (DBT) and interpersonal therapy (IPT), can be incorporated into cognitive behavioral therapy (CBT) to treat complex eating disorder behaviors [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Studies have confirmed that obese BED patients present with severe psychological complications compared to obese non-binge-eating patients and thus require specialized psychological intervention [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p></section><section id="Sec9"><h4 class="pmc_sec_title">Motivational interviewing (MI)</h4>
<p id="Par17">Motivational Interviewing (MI) is a collaborative, patient-centered counseling method designed to resolve ambivalence and enhance a patient’s intrinsic motivation for behavior change. By emphasizing empathy, collaboration, and respect for patient autonomy, MI helps establish a therapeutic partnership and avoids a paternalistic approach that can worsen feelings of stigma [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Evidence supports MI’s effectiveness in promoting healthy behaviors. When employed as a stand-alone intervention, its effects on promoting physical activity in adults typically decrease within a year, despite studies showing that it can considerably reduce central obesity, especially in adolescent females. This suggests that for long-term weight management, MI is most effective when integrated into a comprehensive, continuous support plan [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. The successful implementation of MI in primary care is often hindered by practical challenges, including the need for adequate time for patient-centered discussions, regular follow-up, and specific training in MI techniques, which many primary care providers report they have not received. When used effectively, however, MI can empower patients to overcome obstacles, promote shared decision-making, and lead to more productive conversations about weight. By focusing on active listening and a non-judgmental perspective, MI can also lower the risk of patients having negative counseling experiences [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>].</p></section></section></section><section id="Sec10"><h2 class="pmc_sec_title">Pharmacological interventions</h2>
<p id="Par18">For patients who do not achieve adequate weight loss with lifestyle and behavioral interventions alone, pharmacotherapy is a key adjunctive treatment. The landscape of anti-obesity medications has expanded significantly, offering new mechanisms of action and greater efficacy. Current long-term options include intestinal lipase inhibitors (orlistat), combination agents targeting central appetite pathways (phentermine-topiramate, naltrexone-bupropion), and incretin-based therapies.The development of glucagon-like peptide-1 (GLP-1) receptor agonists (such as liraglutide and semaglutide) and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists (such as tirzepatide) represents a major advancement, demonstrating average weight loss ranging from 5% to over 20% in clinical trials. These agents promote weight loss by suppressing hunger, increasing satiety, and slowing gastric emptying. Emerging therapies, including triple agonists (retatrutide) and novel combinations, promise even greater efficacy in the future. The selection of a pharmacological agent should be individualized based on its efficacy, side effect profile, patient comorbidities, and access, always used as an adjunct to, not a replacement for, ongoing lifestyle modifications. According to current clinical practice guidelines, people with a body mass index (BMI) of ≥ 30 kg/m<sup>2</sup> or ≥ 27 kg/m<sup>2</sup> who also have at least one weight-related comorbidity (such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea) should generally be evaluated for AOMs. Efficacy, safety profile, possible adverse effects, patient comorbidities and preferences, contraindications, drug interactions, cost, and accessibility should all be considered when choosing an AOM (Table <a href="#Tab2" class="usa-link">2</a>) [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Detailed information on specific agents is provided in Supplementary Table <a href="#MOESM1" class="usa-link">3</a>.</p>
<section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Overview of FDA-approved and key emerging pharmacotherapies for chronic weight management in adults</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Medication Class</th>
<th align="left" colspan="1" rowspan="1">Agent(s)</th>
<th align="left" colspan="1" rowspan="1">Mechanism of Action</th>
<th align="left" colspan="1" rowspan="1">Typical Placebo-Subtracted Weight Loss (%)</th>
<th align="left" colspan="1" rowspan="1">Key Common Adverse Events</th>
<th align="left" colspan="1" rowspan="1">Important Considerations/Contraindications</th>
<th align="left" colspan="1" rowspan="1">Representative Citations</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Lipase Inhibitor</td>
<td align="left" colspan="1" rowspan="1">Orlistat</td>
<td align="left" colspan="1" rowspan="1">Inhibits gastric and pancreatic lipases, reducing dietary fat absorption by ~ 30%</td>
<td align="left" colspan="1" rowspan="1">3–5%</td>
<td align="left" colspan="1" rowspan="1">GI: Steatorrhea, oily spotting, fecal urgency</td>
<td align="left" colspan="1" rowspan="1">Malabsorption of fat-soluble vitamins; caution with history of kidney stones (oxalate nephropathy), cholestasis.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLP-1 Receptor Agonist</td>
<td align="left" colspan="1" rowspan="1">Liraglutide 3.0 mg</td>
<td align="left" colspan="1" rowspan="1">Activates GLP-1 receptors; increases satiety, slows gastric emptying, enhances glucose-dependent insulin secretion</td>
<td align="left" colspan="1" rowspan="1">4–6%</td>
<td align="left" colspan="1" rowspan="1">GI: Nausea, vomiting, diarrhea, constipation</td>
<td align="left" colspan="1" rowspan="1">Risk of pancreatitis, gallbladder disease; Boxed warning: thyroid C-cell tumors (rodents); contraindicated in MTC/MEN2 history.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>–<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLP-1 Receptor Agonist</td>
<td align="left" colspan="1" rowspan="1">Semaglutide 2.4 mg</td>
<td align="left" colspan="1" rowspan="1">Activates GLP-1 receptors (as above)</td>
<td align="left" colspan="1" rowspan="1">12–15%</td>
<td align="left" colspan="1" rowspan="1">GI: Nausea, vomiting, diarrhea, constipation</td>
<td align="left" colspan="1" rowspan="1">As above for Liraglutide. Cardiovascular benefits in patients with CVD and obesity.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>, <a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dual GLP-1/GIP Receptor Agonist</td>
<td align="left" colspan="1" rowspan="1">Tirzepatide</td>
<td align="left" colspan="1" rowspan="1">Activates both GLP-1 and GIP receptors</td>
<td align="left" colspan="1" rowspan="1">18–21%</td>
<td align="left" colspan="1" rowspan="1">GI: Nausea, vomiting, diarrhea, constipation</td>
<td align="left" colspan="1" rowspan="1">As above for GLP-1 RAs (pancreatitis, gallbladder, thyroid C-cell tumor warning).</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Opioid Antagonist/Antidepressant</td>
<td align="left" colspan="1" rowspan="1">Naltrexone ER/Bupropion ER</td>
<td align="left" colspan="1" rowspan="1">Affects hypothalamic appetite pathways and brain reward systems</td>
<td align="left" colspan="1" rowspan="1">4–5% (RCTs); ~4% (real-world at 6mo)</td>
<td align="left" colspan="1" rowspan="1">Nausea, constipation, headache, vomiting, insomnia, dizziness</td>
<td align="left" colspan="1" rowspan="1">Boxed warning: suicidal thoughts/behaviors (bupropion); ↑BP/HR; contraindicated in uncontrolled HTN, seizures, MAOI use, opioid use, eating disorders. CV safety ongoing.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>–<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sympathomimetic/Anticonvulsant</td>
<td align="left" colspan="1" rowspan="1">Phentermine/Topiramate ER</td>
<td align="left" colspan="1" rowspan="1">Phentermine suppresses appetite; topiramate enhances satiety (multiple mechanisms)</td>
<td align="left" colspan="1" rowspan="1">7–10%</td>
<td align="left" colspan="1" rowspan="1">Paresthesia, dry mouth, constipation, insomnia, dizziness</td>
<td align="left" colspan="1" rowspan="1">↑HR; Topiramate risks: metabolic acidosis, kidney stones, glaucoma, cognitive effects; Category X (teratogenic - oral clefts); taper on discontinuation.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>, <a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>–<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Emerging: Oral GLP-1 RA</td>
<td align="left" colspan="1" rowspan="1">Orforglipron</td>
<td align="left" colspan="1" rowspan="1">Oral non-peptide GLP-1 receptor agonist</td>
<td align="left" colspan="1" rowspan="1">~ 8–15% (Phase 2/3 data)</td>
<td align="left" colspan="1" rowspan="1">GI: Nausea, vomiting, diarrhea (similar to injectables) Potential for thyroid C-cell tumors (class effect). Full Phase 3 for obesity pending.</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>, <a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>Emerging:</p>
<p>GLP1/GIP/Glucagon RA</p>
</td>
<td align="left" colspan="1" rowspan="1">Retatrutide</td>
<td align="left" colspan="1" rowspan="1">Activates GLP-1, GIP, and glucagon receptors</td>
<td align="left" colspan="1" rowspan="1">Up to ~ 22–24% (Phase 2 data)</td>
<td align="left" colspan="1" rowspan="1">GI: Nausea, vomiting, diarrhea (similar to incretins) Potential for thyroid C-cell tumors (class effect). Phase 3 ongoing.</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>, <a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Emerging: Amylin/GLP-1 RA Combo</td>
<td align="left" colspan="1" rowspan="1">Cagrilintide + Semaglutide</td>
<td align="left" colspan="1" rowspan="1">Combines amylin analogue (satiety) and GLP-1 RA effects</td>
<td align="left" colspan="1" rowspan="1">~ 16–23% (Phase 3 data)</td>
<td align="left" colspan="1" rowspan="1">GI: Nausea, vomiting, diarrhea (similar to GLP-1 RAs) Potential for thyroid C-cell tumors (semaglutide component). Regulatory filing planned.</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>, <a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p28">
<p>Weight loss percentages are approximate mean values from key clinical trials or reviews, typically representing additional weight loss compared to placebo over 1 to 1.5 years, unless otherwise specified. Individual results may vary</p>
<p>ER = Extended Release; GI = Gastrointestinal; GLP−1 RA = Glucagon−like Peptide−1 Receptor Agonist; GIP = Glucose−dependent Insulinotropic Polypeptide; MTC = Medullary Thyroid Carcinoma; MEN2 = Multiple Endocrine Neoplasia syndrome type 2; BP = Blood Pressure; HR = Heart Rate; HTN = Hypertension; MAOI = Monoamine−Oxidase Inhibitor; CVD = Cardiovascular Disease</p>
<p>Emerging agents are investigational and not yet FDA−approved for obesity; efficacy and safety data are based on reported trial results and may evolve</p>
<p>All AOMs should be used as an adjunct to a reduced−calorie diet and increased physical activity</p>
</div></div></section><section id="Sec11"><h3 class="pmc_sec_title">Limitations of existing studies</h3>
<p id="Par21">It is critical, however, to interpret the impressive efficacy data from these landmark trials with caution due to significant limitations in their real-world applicability. Recent analyses reveal that the populations recruited for major trials like SELECT and SURMOUNT are not representative of the true U.S. obese population in terms of age, sex, and race. Specifically, Black participants have been consistently underrepresented across these trials, while female participants were disproportionately represented in some key studies. This demographic mismatch creates an “evidence-practice gap,” meaning the results cannot be uncritically extrapolated to all patient populations seen in a typical primary care setting. Therefore, clinicians must be critical consumers of this data, and there is a pressing need for real-world evidence (RWE) studies to supplement trial findings and contextualize the effectiveness of these agents across diverse, real-world populations.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Safety and monitoring</h3>
<p id="Par22">Careful patient selection, customized treatment plans, and careful ongoing monitoring are necessary for the safe and effective use of pharmaceutical treatments for obesity in order to maximize effectiveness and minimize potential side effects. To evaluate medication adherence, tolerability, the emergence of any side effects, and treatment response (in terms of weight loss and improvement in obesity-related comorbidities), routine follow-up appointments are crucial [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>].</p>
<section id="Sec13"><h4 class="pmc_sec_title">Baseline assessment and patient selection</h4>
<p id="Par23">A thorough baseline assessment is essential prior to starting any AOM. This consists of a comprehensive medical history (including substance abuse, mental health issues, and previous attempts to lose weight), a physical examination (including measurements of vital signs and waist circumference), and pertinent laboratory tests. To rule out untreated hypothyroidism as a factor in weight gain, standard laboratory tests may include a thyroid-stimulating hormone (TSH), a lipid panel, a complete blood count, a comprehensive metabolic panel (including renal and liver function tests, electrolytes), fasting glucose and HbA1c, and a metabolic panel. Every medication’s unique contraindications need to be carefully examined and recorded. The patient’s comorbidities (such as the presence of T2DM, CVD, hypertension, mood disorders, seizure history, and gallbladder disease), concurrent medications (to prevent drug interactions), patient preferences, lifestyle factors, and potential financial or insurance coverage should all be taken into consideration when choosing an AOM. For instance, GLP-1 RAs and tirzepatide should be avoided by patients with a history of pancreatitis, medullary thyroid cancer, or MEN2 [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Naltrexone-bupropion shouldn’t be given to people who have uncontrolled hypertension, a history of seizures, are taking MAOIs, or are on opioids [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. The teratogenic risks of substances such as phentermine-topiramate and the importance of using effective contraception throughout treatment must be thoroughly explained to women of childbearing age; a negative pregnancy test should be verified prior to starting treatment and checked on a monthly basis [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>].</p></section><section id="Sec14"><h4 class="pmc_sec_title">Monitoring efficacy and adverse events</h4>
<p id="Par24">After starting treatment or achieving the desired maintenance dosage, the weight loss response to an AOM should normally be evaluated three to four months later. According to guidelines, a medication should be reevaluated if a patient has not lost a clinically significant amount of weight by this point (e.g., at least 5% of their starting body weight, a lower threshold for some medications like orlistat, or as indicated by the drug’s labeling). The current AOM may be stopped, a different agent with a different mode of action may be used, or combination therapy may be considered if necessary. Common gastrointestinal side effects, such as nausea, vomiting, diarrhea, and constipation, are common during dose initiation and titration for the highly effective incretin mimetics, such as tirzepatide and GLP-1 RAs [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. These frequently call for proactive management techniques, such as recommending dietary changes to patients (e.g., eating smaller, more frequent, low-fat meals and avoiding trigger foods), starting at the lowest dose and increasing very gradually (e.g., every 4 weeks), and making sure patients are getting enough water. Patients taking sympathomimetic medications such as naltrexone-bupropion or phentermine (either alone or in combination with topiramate) should have their heart rates monitored. Additionally, since naltrexone-bupropion can raise blood pressure, it is important to keep an eye on it [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Because naltrexone-bupropion contains bupropion, patients’ mental health status, including mood swings, depression, and suicidal thoughts, should be regularly evaluated. Maintaining proper hydration to lower the risk of kidney stones, keeping an eye out for ocular symptoms like pain or blurred vision, and keeping an eye out for signs of metabolic acidosis, such as fatigue or hyperventilation, are crucial for patients taking phentermine-topiramate. Patients with pre-existing kidney disease or those with specific AOMs may benefit from periodic evaluations of renal function [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>].</p></section><section id="Sec15"><h4 class="pmc_sec_title">Long-term use and “Off-ramping”</h4>
<p id="Par25">Similar to diseases like type 2 diabetes or hypertension, obesity is acknowledged as a chronic, relapsing illness. Since many AOMs are therefore authorized for long-term use, it may be necessary to continue pharmacotherapy indefinitely in order to sustain the weight loss and related health benefits. Partial or total weight gain is frequently linked to stopping AOMs, especially the stronger ones. This biological fact emphasizes the disease’s chronic character and the function of drugs in controlling the underlying physiological causes of weight. However, there is still much clinical debate and ongoing research regarding the ideal length of treatment, particularly for the more recent, highly effective, and frequently expensive incretin mimetics. In order to safely and effectively taper or stop these medications while minimizing weight regain and transferring patients to other sustainable weight maintenance strategies (which may include less intensive AOMs, or intensified lifestyle and behavioral interventions alone), there is currently little evidence and a lack of established guidelines on “off-ramping” strategies. Continuous efficacy, tolerability, patient preference, cost, and a careful balance of risks and benefits in a collaborative decision-making process with the patient should all be taken into consideration when making decisions about the long-term continuation or discontinuation of AOMs.</p></section><section id="Sec16"><h4 class="pmc_sec_title">Cost-effectiveness and access</h4>
<p id="Par26">For many patients and healthcare systems, the cost of AOMs—especially the more recent generation of GLP-1 RAs and dual agonists like tirzepatide—is a major factor and a major access barrier. Although these medications provide previously unheard-of weight loss and proven cardiometabolic advantages (such as lowering cardiovascular risk with semaglutide), their exorbitant list costs may be unaffordable. If access is restricted to people who can afford to pay out-of-pocket or have full insurance coverage, this financial burden may worsen health disparities.</p>
<p id="Par27">Cost-effectiveness analyses (CEAs) for these more recent AOMs have produced inconsistent and occasionally contradictory results, which are frequently heavily influenced by the particular comparators, the analysis’s time horizon (lifetime vs. short-term), the payers’ willingness-to-pay (WTP) threshold, and presumptions regarding price negotiations and long-term efficacy. For example, a 2025 CEA indicated that, over a 68-week period, subcutaneous tirzepatide might be more cost-effective than oral semaglutide, with an incremental cost-effectiveness ratio (ICER) of $34,212 for each quality-adjusted life-year (QALY) gained. Another 2025 lifetime CEA, however, found that tirzepatide and semaglutide were not cost-effective at their current net prices and that significant price reductions were necessary to reach a common WTP threshold of $100,000/QALY (30.5% for tirzepatide and 81.9% for semaglutide). However, naltrexone-bupropion was found to be more cost-effective in the same study. Although orlistat is typically less costly, its effectiveness is also more modest. This variation in CEA results emphasizes how difficult it is to determine economic value. Policymakers and PCPs need to understand that “cost-effective” is not a fixed concept and that various analyses may produce varying results, which makes resource allocation decisions difficult.</p>
<p id="Par28">Primary care doctors are frequently at the forefront of navigating these complexities, advocating for patients’ access to appropriate therapies and talking with patients about treatment options while keeping the financial implications in mind. Health systems are also struggling with how to control the financial impact of these expensive but efficient drugs. In order to control costs and primary care capacity while guaranteeing that foundational lifestyle interventions are in place, NHS England, for instance, is putting tirzepatide into primary care through a phased rollout strategy, prioritizing access based on comorbidity burden and requiring companion wraparound lifestyle support. This strategy presents a viable real-world model for striking a balance between comprehensive care, cost containment, and clinical need.</p></section></section></section><section id="Sec17"><h2 class="pmc_sec_title">Comparative effectiveness and shared decision-making</h2>
<p id="Par29">When choosing between behavioral and pharmacological interventions, clinicians and patients must navigate a fundamental trade-off between safety and efficacy. A major systematic review for the US Preventive Services Task Force found that while behavior-based interventions are associated with a lower risk of harms, medication-based interventions lead to substantially greater weight loss. For instance, meta-analyses show behavior-based interventions result in a mean weight loss of approximately 2.4 kg at 12–18 months, whereas pharmacotherapy can achieve weight loss ranging from 5% to over 20% of total body weight. This evidence highlights the need to move away from a rigid, one-size-fits-all approach toward a flexible model centered on shared decision-making, as strongly advocated by the 2025 American Diabetes Association (ADA) guidelines. This patient-centered approach allows for the alignment of treatment with an individual’s specific health profile, risk tolerance, and personal goals.</p></section><section id="Sec18"><h2 class="pmc_sec_title">Role of self-monitoring and digital tools</h2>
<p id="Par30">A key component of behavioral support that should continue in conjunction with medication is patient self-monitoring of weight, food consumption, and physical activity. The emergence of digital health technologies, such as wearable activity trackers, smartphone apps, and online health platforms, provides scalable and easily accessible tools to support self-monitoring and offer continuous behavioral education and support. There is growing evidence that using these digital tools in conjunction with AOM therapy can improve weight loss results and increase patient engagement. A 2025 study, for instance, discovered that patients utilizing GLP-1 RAs who actively participated in a digital weight management platform lost a significantly higher amount of weight than those who did not [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>].</p></section><section id="Sec19"><h2 class="pmc_sec_title">Integrating behavioral and pharmacological interventions</h2>
<p id="Par31">A synergistic combination of behavioral interventions and pharmacotherapy is frequently the best way to manage obesity since this strategy addresses the disease’s biological and behavioral causes. Patients who receive behavioral therapies and lifestyle changes are equipped with the fundamental knowledge and techniques needed to make long-lasting adjustments to their eating patterns and levels of physical activity. In turn, pharmacotherapy can help overcome physiological adaptations (like increased appetite or decreased metabolic rate) that encourage weight regain, increase the effectiveness of these lifestyle modifications, and improve adherence to the treatment plan as a whole.</p>
<p id="Par32">The improved results from such integrated care are supported by evidence. A “step-up” strategy, for example, has shown promise in adding AOMs for patients who are early nonresponders to behavioral treatment alone. According to a 2025 randomized controlled trial, patients who started behavioral therapy (BT) with less than 2% weight loss and then continued BT with phentermine added experienced significantly more weight loss at 24 weeks (mean 5.9%) than those who continued BT with a placebo (mean 2.8%). By directing AOMs to those who are most likely to need them in order to achieve clinically significant weight loss, this approach enables a customized intensification of treatment based on initial patient response, potentially optimizing outcomes and resource use.</p>
<p id="Par33">Similarly, concurrent and continuous behavioral support is regarded as essential, not just an optional add-on, for patients starting the more recent, highly effective AOMs, such as tirzepatide or GLP-1 receptor agonists. This support should be multimodal, with an emphasis on promoting adherence to the medication regimen, managing potential medication side effects (e.g., offering dietary advice to mitigate gastrointestinal issues common with incretin mimetics), and creating and reinforcing healthy eating and physical activity patterns. For long-term weight control, these learned behaviors are essential, particularly if AOMs are eventually tapered or stopped. The use of digital health platforms to provide this kind of integrated care in a scalable way is growing. In addition to facilitating communication with the healthcare team, these platforms can offer tools for self-monitoring of diet, activity, and symptoms, as well as individualized coaching and educational materials. According to a 2025 retrospective cohort study, among people prescribed GLP-1 receptor agonists, active use of a digital weight management platform significantly improved weight loss outcomes (e.g., an additional 3.5% points of weight loss at 5 months for engaged versus non-engaged users). This synergy—where digital tools offer easily accessible behavioral support and AOMs provide a substantial biological push for weight loss—represents a potent new paradigm for supported self-management in the treatment of obesity.</p>
<p id="Par34">It is possible to strategically incorporate particular behavioral therapies. When co-occurring psychological disorders like emotional eating, body image distress, or binge eating disorder (BED) are present, cognitive behavioral therapy (CBT) can be especially helpful. Cognitive behavioral therapy (CBT) assists patients in addressing maladaptive thought patterns and creating coping mechanisms that medication alone is unable to address. Throughout the course of treatment, PCPs can use the beneficial communication technique known as Motivational Interviewing (MI). Enhancing patient engagement, addressing ambivalence about beginning or maintaining medication or lifestyle changes, and facilitating truly shared decision-making regarding the integrated treatment plan are all possible with MI.</p>
<p id="Par35">In the end, a customized and flexible strategy is essential for effective integration. The needs of each patient, their psychological profile, the particular AOM being used (and its side effect profile), and the stage of treatment at hand (e.g., initiation, weight loss, weight maintenance, or potential medication tapering) should all be taken into consideration when determining the type and intensity of behavioral support. Strong communication and teamwork are frequently necessary for effective integration, and this may entail a multidisciplinary team consisting of the PCP, a registered dietitian, a psychologist or behavioral therapist, and a pharmacist who are all working toward the same patient-centered objectives. By acknowledging obesity as a chronic condition that necessitates continuous support rather than acute, episodic treatment, this integrated, long-term management approach is crucial [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>].</p></section><section id="Sec20"><h2 class="pmc_sec_title">Challenges in primary care obesity management</h2>
<p id="Par36">There are many obstacles to managing obesity in primary care, such as the stigma associated with weight, the inability to identify and treat obesity as a chronic illness, and a lack of behavioral counseling and nutrition education. Time restraints, misaligned financial incentives, and restricted access to multidisciplinary support are some of the challenges faced by providers. Comorbid conditions like PCOS, hypothyroidism, and depression impact metabolism, hormonal balance, and patient motivation at the patient level and make management more difficult. Although they have a weak connection to primary care, family and community environments also have a big impact on health behaviors. A methodical, evidence-based strategy is required to get past these obstacles. This includes advocating for payment models, team-based care models, streamlined referral processes, improved medical school curricula, and easily accessible continuing medical education. Effective interventions must involve the whole family and make use of available resources. In primary care, digital health tools such as telehealth platforms and mobile apps can alleviate time and resource constraints by extending care reach, improving patient engagement, and providing real-time data.</p>
<section id="Sec21"><h3 class="pmc_sec_title">Time restrictions and clinical workload</h3>
<p id="Par37">One often mentioned challenge is the considerable time limit during regular primary care visits. Being a complex chronic illness, obesity calls for a comprehensive assessment, individualized advice on lifestyle changes (diet, exercise, and behavior), an in-depth discussion of the benefits and drawbacks of AOMs, management of comorbidities, and ongoing observation. Usually in a normal 10 to 15 min appointment, it is difficult to sufficiently handle these complicated problems, which leads to little conversation or an emphasis on more pressing concerns.</p>
<p id="Par38">Many PCPs say they did not get enough instruction and training in managing obesity throughout medical school, residency, and even continuing medical education. Particularly with regard to the rapidly evolving field of AOMs, their mechanisms, efficacy, side effects, and appropriate patient selection, this may cause gaps in knowledge of the most recent evidence-based recommendations. Lack of specialized training can also lead to lowered confidence in beginning weight-related discussions, providing successful behavioral counseling, supervising medication, or handling patient ambivalence. In Saudi Arabia, for instance, a 2025 cross-sectional study found that although most PCPs (70.7%) had a moderate attitude toward obesity, more than half (57%) said they would want additional training in obesity counseling, and their self-reported practice levels were often moderate to poor. This shows how urgently worldwide better educational programs are needed. These challenges are not merely anecdotal; a 2025 joint clinical perspective from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) identified insufficient time, inadequate training, and poor reimbursement as primary barriers impeding optimal care in the primary care setting [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>].</p></section><section id="Sec22"><h3 class="pmc_sec_title">Attitudes of clinicians: bias, weight stigma, and attachment</h3>
<p id="Par39">Among healthcare professionals, including PCPs, weight bias—unfavorable attitudes, beliefs, and stereotypes—and weight stigma—social devaluation and mistreatment based on weight—are rather common and especially detrimental problems. Explicit or unconscious, these prejudices can manifest as ideas that obese patients are unmotivated, uncooperative, or reluctant. Less respectful communication, a more directive rather than a cooperative approach, poor provision of care, and even a resistance to offer evidence-based treatments can follow from this. Patients who feel weight stigma are those who experience or see shamed, judged, and disrespected by their healthcare providers. These negative events can lead to poorer health outcomes and more psychological distress; they can also cause people to avoid medical care (including preventive services), have less faith in medical professionals, be reluctant to discuss weight-related issues, and not follow treatment advice. The 2025 American Diabetes Association (ADA) Standards of Care on weight bias and the 2023 American Association of Clinical Endocrinology (AACE) Consensus Statement on Stigma and Bias call for healthcare systems and professionals to actively detect and address weight bias. Person-first language (e.g., “person with obesity” instead of “obese person”), establishing a friendly and inclusive clinical setting (e.g., making sure that gowns, blood pressure cuffs, and examination tables are available in suitable sizes), obtaining consent before discussing weight, and having compassionate, nonjudging conversations that emphasize health rather than just weight figures are all important tactics. Key strategies include using person-first language, ensuring the clinical environment is physically accommodating (e.g., appropriate-sized equipment), and asking for permission before initiating weight-related discussions [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>].</p></section><section id="Sec23"><h3 class="pmc_sec_title">Adherence problems and patient-based characteristics</h3>
<p id="Par40">Managing obesity is mostly difficult when one lacks patient adherence to long-term behavioral changes (diet and exercise) and medication schedules. Some of the many elements influencing adherence are individual motivation levels, socioeconomic constraints (e.g., the cost of healthy foods, access to safe places for physical activity, and affordability of medications), mental health comorbidities (e.g., depression, anxiety, or BED, which can impact coping mechanisms and motivation), a lack of social support, prior negative experiences with weight management attempts, or stigmatizing interactions within the healthcare system. Patients may also hold false opinions regarding the causes of obesity or the effectiveness and safety of different treatments. A strong support network—including peers, family, and healthcare providers—is absolutely vital, based on a 2023 systematic review on patient-reported obstacles and facilitators to implementing lifestyle interventions in primary care. Furthermore crucial are tailored individualized lifestyle intervention programs for every person’s particular situation, preferences, and objectives. Though they generally value their PCP’s participation in their weight management path, patients may become annoyed by inconsistent follow-up, a lack of tailored advice, or a perceived lack of knowledge of the daily challenges they face in managing their weight. Improving adherence and results calls for an awareness of these patient-specific challenges and how to get beyond them by cooperative problem-solving and sympathetic communication.</p>
<p id="Par41">Systemic and Reimbursement Issues: Apart from issues involving particular doctors and patients, systematic problems in healthcare systems create major challenges. Many times, the comprehensive obesity counseling and management tools provided in primary care are not sufficiently reimbursed. This financial disincentive may make it difficult for practices to commit the time and resources (such as specialized dietitians or health educators) needed for intense obesity treatment. Limited access to specialized obesity treatment resources—such as multidisciplinary weight management programs, bariatric surgery centers, and reasonably priced AOMs—allows PCPs and their patients less choices as well. Furthermore hampered by care fragmentation and poor communication between primary care and specialized services is effective management. Often necessary to remove these institutional barriers and ensure that obesity is recognized and compensated as a chronic illness needing all-encompassing, long-term treatment are local, state, and federal policy changes.</p>
<p id="Par42">Though PCPs are very important in controlling obesity, the best treatment usually calls for a multidisciplinary team approach including dietitians, psychologists or behavioral therapists, exercise physiologists or physical therapists, and occasionally bariatric surgeons or obesity medicine specialists. Access to these combined multidisciplinary services is often limited, though, particularly in rural or underprivileged areas or in response to limited insurance coverage. This forces PCPs to supervise all aspect of obesity treatment, usually without the required tools or support. When compared to normal treatment, a 2024 RCT carried out in a rural area revealed the benefits of an interdisciplinary obesity care model (NP-led with support from a dietitian, physiotherapist, and psychologist). Showing sustained weight loss and improved diabetes control over a 2-year period, this RCT revealed.</p>
<p id="Par43">Integration of New Technologies and Treatments: Highly successful AOMs present opportunities as well as challenges related to the rapid development of new technologies (such as digital health tools and AI-powered decision support) Particularly with regard to the efficacy, negative effects, and cost of new drugs, PCPs may find it challenging to remain current on the most recent studies, figure out how to effectively include these new resources and therapies into their practice, and control patient expectations. Clinical decision support systems (CDSS) are being developed to assist PCPs; nevertheless, their usability and workflow integration must be carefully considered in order to prevent alert fatigue or disturbance. For a weight management CDSS, for example, a 2025 proof-of-concept study found that although it raised PCP self-efficacy and self-reported clinical practice habits, issues with patient engagement—completing questionnaires—and PCP perception of productivity persisted. These linked problems complicate the primary care management of obesity. Dealing with them effectively will call for a multifarious strategy including efforts against weight stigma, legislative changes to support comprehensive care, improvements in medical education, and the development of fresh care models better serving patients and PCPs.</p></section></section><section id="Sec24"><h2 class="pmc_sec_title">Strategies for overcoming challenges in primary care</h2>
<p id="Par44">The complex issue of obesity in primary care requires a multifaceted approach that incorporates improvements in therapeutic interventions, policy reforms, medical education and training, and the development of patient-centered and equitable care models. Future research must focus on adapting study findings into practical, expandable, and long-lasting primary care approaches. To overcome existing challenges, a structured approach is needed. The OMA and ACOFP advocate for a model based on four pillars of care including nutrition therapy, physical activity, behavior modification, and medical interventions. Optimizing outcomes involves systematically addressing each of these pillars [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>].</p>
<section id="Sec25"><h3 class="pmc_sec_title">Enhancing medical education and PCP training</h3>
<p id="Par45">A crucial first step is to improve obesity education at all levels of medical school, residency, and continuing medical education for PCPs in practice. Curriculum that go beyond basic pathophysiology should cover the pharmacology of AOMs (including newer agents), practical nutrition and physical activity prescription, evidence-based behavioral counseling techniques (such as MI and CBT adapted for primary care), management of AOM side effects, and strategies for addressing weight stigma and bias. To improve empathy and communication skills, training should include experiential learning methods like standardized patient encounters or reflective practice. The “5As of Obesity Management” (Ask, Assess, Advise, Agree, Assist) framework has been shown to boost residents’ competence and confidence in obesity counseling when integrated into comprehensive training programs. It also provides a useful framework for guiding consultations. The development of practical, evidence-based clinical guidelines and primary care-specific decision-support materials are further ways to empower PCPs. The OMA/ACOFP 2025 joint clinical perspective places a high priority on providing helpful resources regarding the four pillars of obesity management (diet, exercise, behavior modification, and medical interventions) in order to assist primary care physicians.</p></section><section id="Sec26"><h3 class="pmc_sec_title">Policy changes to promote all-inclusive obesity care</h3>
<p id="Par46">Promoting legislative changes is essential to creating a healthcare environment that supports effective obesity management. This involves advocating for equitable remuneration for the laborious obesity treatment and counseling services rendered in primary care, which is currently a major barrier. Better insurance coverage for evidence-based interventions, including behavioral programs, bariatric surgery, and AOMs (especially more recent, more costly, but more effective agents), is necessary to ensure equitable access to care. Policies that make multidisciplinary teams easier to access or integrate into primary care can also improve the quality of care. Additionally, public health policies that look for improving food environments and encourage physical activity at the population level, can support individual efforts made in clinical settings.</p></section><section id="Sec27"><h3 class="pmc_sec_title">Advances in novel and pharmacological treatments</h3>
<p id="Par47">Research on new pharmacological treatments must continue. The success of GLP-1 RAs and dual GLP-1/GIP agonists has encouraged more research into multi-agonist therapies (e.g., tri-agonists like retatrutide) and novel mechanisms of action that may offer even greater efficacy or improved tolerability. The development of effective oral formulations of incretin mimetics, like orforglipron, may significantly increase patient convenience and adherence. Research should also focus on long-term safety and efficacy, cardiovascular outcomes of novel agents, techniques for sequencing or combining medications, and identifying predictors of response to specific AOMs in order to enable more customized prescribing. Research on gene-based therapies, the role of the gut microbiota in obesity, and the creation of innovative bariatric procedures is still ongoing, despite the fact that they are currently farther from being widely used in primary care.</p>
<p id="Par48">The development of distinct “off-ramping” techniques for patients who have used potent AOMs to achieve notable weight loss should be the main goal of future pharmacological research. Understanding how to taper or stop taking these medications while preventing weight gain—possibly by relying on highly reinforced behavioral techniques or transferring to less intense AOMs—is an important unmet need.</p></section><section id="Sec28"><h3 class="pmc_sec_title">Developing equitable and patient-centered care models</h3>
<p id="Par49">Future obesity treatment models must prioritize equity and patient-centeredness. At every level of the healthcare system, it includes thoroughly dealing with stigma and bias related to weight. Healthcare professionals must be trained to provide collaborative, respectful, and nonjudgmental care, acknowledging the patient as an expert in their own life and preferences. Care models should be sensitive to cultural differences and tailored to the specific needs and financial situations of different patient populations. This might mean hiring community health workers, reaching out to underserved communities via telehealth, and ensuring that educational resources and programs are accessible and culturally appropriate.</p>
<p id="Par50">Patient-reported outcome measures (PROMs) must be more systematically incorporated into routine clinical practice in order to provide truly patient-centered care. From the perspective of the patient, PROMs provide a more complete picture of treatment success, capturing not only weight loss but also improvements in physical function, symptoms, self-esteem, and satisfaction with care. A core set of PROMs for clinical obesity care includes measures like the BODY-Q (covering physical function, symptoms, psychological function, social function, eating behavior, and body image) and the IWQOL-Lite (for self-esteem). These information can be collected in a systematic way and utilized to improve collaborative decision-making and personalize treatment regimens.</p></section><section id="Sec29"><h3 class="pmc_sec_title">Using technology in digital health</h3>
<p id="Par51">The management of obesity in primary care could be greatly enhanced by advancements in digital health. AI-powered clinical decision support systems (CDSS) can assist PCPs with risk stratification, treatment selection, and adherence to guidelines, but their integration into clinical workflows must be optimized to ensure usability and avoid alert fatigue. Telemedicine can improve access to care and allow for more frequent, quick check-ins for monitoring and support, especially for patients who live in remote areas or have limited mobility. Wearable technology and mobile health (mHealth) apps can provide patients with the tools to self-monitor their weight, sleep habits, level of physical activity, and diet, in addition to providing personalized feedback and motivation. There is growing evidence that incorporating AOMs with digital health platforms can enhance weight loss outcomes by providing structured behavioral support. However, after six months, there is a chance of weight regain and the effectiveness of smartphone-only apps for managing weight without comorbidities appears to be limited. This implies that apps might need to be more individualized and incorporated into broader care models in order to sustain long-term benefits. Ensuring data privacy, security, and digital equity is crucial as these technologies become more widely used.</p></section><section id="Sec30"><h3 class="pmc_sec_title">Prioritize implementation science</h3>
<p id="Par52">Finally, to understand how to successfully integrate evidence-based obesity interventions into routine primary care practices, a greater focus on implementation science is needed. This includes researching implementation enablers and barriers, evaluating different service delivery models (e.g., shared medical appointments, team-based care, and integration with community resources), and developing strategies to promote the adoption and sustainability of effective practices. NHS England’s phased implementation plan for tirzepatide in primary care, which includes defined models of care, mandatory wraparound lifestyle support, and specific cohorting, is an example of a health system attempting to operationalize the rollout of new, complex interventions. Learning from such initiatives will be crucial to scaling up effective obesity care globally.</p></section></section><section id="Sec31"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par53">Obesity, is a chronic public health trend that needs thorough management, mainly in primary care settings. The basis for effective treatment is behavioral interventions, which can be lifestyle modifications and physical activity. Behavioral therapies, such as CBT and MI, are of vital importance in keeping patients compliant over time with the introduced lifestyle modifications. Pharmacological treatments, including GLP-1 receptor agonists and combination therapies like Naltrexone-Bupropion, can further support weight loss and metabolic health for those who cannot make lifestyle changes alone. Also, Primary care providers have a crucial role in managing obesity; however, there are certain barriers: time constraints, lack of training, and patient compliance. Overcoming these barriers will be very useful in the management of obesity. Future efforts should be directed at improving medical education, advocating for policy changes that promote better access to care, and using digital health technologies to improve patient engagement and adherence. Innovations such as AI-powered decision support, telemedicine, and wearable devices are promising ways to monitor patient progress and provide timely feedback. Finally, effective management of obesity as a global health crisis needs a multi-faceted strategy that integrates evidence-based behavioral and pharmacological approaches, addresses systemic challenges, and puts personalized care at the forefront.</p></section><section id="Sec32"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12372397/bin/13098_2025_1925_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (14.6KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>None.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>M.K conceptualized the study, conducted the literature search, designed the tables, drafted the initial manuscript, and performed critical revisions. R.A carried out the literature review, extracted data for table compilation, and drafted sections on the theoretical framework. A.EN developed the overall methodology, selected and curated studies for inclusion in the tables, and edited the content. S.H.B performed thematic analysis, structured and formatted the tables, and prepared visual elements as needed. M.H managed references and formatted the tables according to journal guidelines. A.S.S interpreted the clinical implications, carried out writing-review and editing tasks. K.R reviewed the final manuscript and provided scientific supervision and guidance and gave final approval of the manuscript. R.P oversaw project administration and conceptualization, supervised all stages of the work, handled correspondence with the journal, and coordinated preparation of the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>No funds, grants, or other support was received.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par54">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par55">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par56">The authors declare no competing interests.</p></section><section id="FPar4"><h3 class="pmc_sec_title">Consent to participate</h3>
<p id="Par57">Not applicable.</p></section><section id="FPar5"><h3 class="pmc_sec_title">Data access statement</h3>
<p id="Par58">Not applicable.</p></section><section id="notes10"><p>This study is not a clinical trial. Registration details not applicable.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Carpena Lucas PJ, Sánchez-Cubo F, Vargas Vargas M, Mondéjar Jiménez J. Influence of lifestyle habits in the development of obesity during adolescence. Int J Environ Res Public Health. 2022;19(7):4124.
</cite> [<a href="https://doi.org/10.3390/ijerph19074124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8998286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35409807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carpena%20Lucas%20PJ,%20S%C3%A1nchez-Cubo%20F,%20Vargas%20Vargas%20M,%20Mond%C3%A9jar%20Jim%C3%A9nez%20J.%20Influence%20of%20lifestyle%20habits%20in%20the%20development%20of%20obesity%20during%20adolescence.%20Int%20J%20Environ%20Res%20Public%20Health.%202022;19(7):4124." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41.
</cite> [<a href="https://doi.org/10.1001/jama.2009.2014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20071471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Flegal%20KM,%20Carroll%20MD,%20Ogden%20CL,%20Curtin%20LR.%20Prevalence%20and%20trends%20in%20obesity%20among%20US%20adults,%201999%E2%80%932008.%20JAMA.%202010;303(3):235%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027–50.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(23)02750-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7615769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38432237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Phelps%20NH,%20Singleton%20RK,%20Zhou%20B,%20Heap%20RA,%20Mishra%20A,%20Bennett%20JE,%20et%20al.%20Worldwide%20trends%20in%20underweight%20and%20obesity%20from%201990%20to%202022:%20a%20pooled%20analysis%20of%203663%20population-representative%20studies%20with%20222%20million%20children,%20adolescents,%20and%20adults.%20Lancet.%202024;403(10431):1027%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Kann L. Youth risk behavior surveillance—United states, 2017. MMWR Surveillance Summaries. 2018;67.</cite> [<a href="https://doi.org/10.15585/mmwr.ss6708a1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6002027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29902162/" class="usa-link">PubMed</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>World Health O. Consideration of the evidence on childhood obesity for the Commission on Ending Childhood Obesity: report of the ad hoc working group on science and evidence for ending childhood obesity, Geneva, Switzerland. Geneva: World Health Organization; 2016 2016.</cite>
</li>
<li id="CR6">
<span class="label">6.</span><cite>Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity management in adults: A review. JAMA. 2023;330(20):2000–15.
</cite> [<a href="https://doi.org/10.1001/jama.2023.19897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11325826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38015216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elmaleh-Sachs%20A,%20Schwartz%20JL,%20Bramante%20CT,%20Nicklas%20JM,%20Gudzune%20KA,%20Jay%20M.%20Obesity%20management%20in%20adults:%20A%20review.%20JAMA.%202023;330(20):2000%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Ng M, Gakidou E, Lo J, Abate YH, Abbafati C, Abbas N, et al. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. The Lancet.2025;405(10481):813 – 38.</cite> [<a href="https://doi.org/10.1016/S0140-6736(25)00355-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11920007/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40049186/" class="usa-link">PubMed</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Mahase E. Global cost of overweight and obesity will hit $4.32tn a year by 2035, report warns. BMJ. 2023;380:p523.</cite> [<a href="https://doi.org/10.1136/bmj.p523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36868577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mahase%20E.%20Global%20cost%20of%20overweight%20and%20obesity%20will%20hit%20%244.32tn%20a%20year%20by%202035,%20report%20warns.%20BMJ.%202023;380:p523." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Talab SMM, Bigdelu L, Niknafs P, Shah MU, Naqvi SY, Rezaiyan MK. Impact of obesity on echocardiographic parameters in individuals free of CVD using anthropometric measurements. Br J Cardiol. 2024;31(3):035.
</cite> [<a href="https://doi.org/10.5837/bjc.2024.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11795916/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39917564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Talab%20SMM,%20Bigdelu%20L,%20Niknafs%20P,%20Shah%20MU,%20Naqvi%20SY,%20Rezaiyan%20MK.%20Impact%20of%20obesity%20on%20echocardiographic%20parameters%20in%20individuals%20free%20of%20CVD%20using%20anthropometric%20measurements.%20Br%20J%20Cardiol.%202024;31(3):035." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Haire-Joshu D, Klein S. Is primary care practice equipped to deal with obesity? Comment on preventing weight gain by lifestyle intervention in a general practice setting. Arch Intern Med. 2011;171(4):313–5.
</cite> [<a href="https://doi.org/10.1001/archinternmed.2011.3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3607436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21357806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haire-Joshu%20D,%20Klein%20S.%20Is%20primary%20care%20practice%20equipped%20to%20deal%20with%20obesity?%20Comment%20on%20preventing%20weight%20gain%20by%20lifestyle%20intervention%20in%20a%20general%20practice%20setting.%20Arch%20Intern%20Med.%202011;171(4):313%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Wadden TA, Volger S, Tsai AG, Sarwer DB, Berkowitz RI, Diewald LK, et al. Managing obesity in primary care practice: an overview with perspective from the POWER-UP study. Int J Obes (Lond). 2013;37(0 1):S3–11.
</cite> [<a href="https://doi.org/10.1038/ijo.2013.90" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3786742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23921779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wadden%20TA,%20Volger%20S,%20Tsai%20AG,%20Sarwer%20DB,%20Berkowitz%20RI,%20Diewald%20LK,%20et%20al.%20Managing%20obesity%20in%20primary%20care%20practice:%20an%20overview%20with%20perspective%20from%20the%20POWER-UP%20study.%20Int%20J%20Obes%20(Lond).%202013;37(0%201):S3%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Moiz A, Filion KB, Toutounchi H, Tsoukas MA, Yu OHY, Peters TM, et al. Efficacy and safety of Glucagon-Like Peptide-1 receptor agonists for weight loss among adults without diabetes: A systematic review of randomized controlled trials. Ann Intern Med. 2025;178(2):199–217.
</cite> [<a href="https://doi.org/10.7326/ANNALS-24-01590" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39761578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moiz%20A,%20Filion%20KB,%20Toutounchi%20H,%20Tsoukas%20MA,%20Yu%20OHY,%20Peters%20TM,%20et%20al.%20Efficacy%20and%20safety%20of%20Glucagon-Like%20Peptide-1%20receptor%20agonists%20for%20weight%20loss%20among%20adults%20without%20diabetes:%20A%20systematic%20review%20of%20randomized%20controlled%20trials.%20Ann%20Intern%20Med.%202025;178(2):199%E2%80%93217." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Gurney M, Gorstein J. The global prevalence of obesity-an initial overview of available data. World Health Stat Q. 1988;41(3–4):251–4.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/3232412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gurney%20M,%20Gorstein%20J.%20The%20global%20prevalence%20of%20obesity-an%20initial%20overview%20of%20available%20data.%20World%20Health%20Stat%20Q.%201988;41(3%E2%80%934):251%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes–2025. Diabetes Care. 2025;48(Supplement1):S167–80.
</cite> [<a href="https://doi.org/10.2337/dc25-S008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11635032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39651976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?8.%20Obesity%20and%20weight%20management%20for%20the%20prevention%20and%20treatment%20of%20type%202%20diabetes:%20standards%20of%20care%20in%20diabetes%E2%80%932025.%20Diabetes%20Care.%202025;48(Supplement1):S167%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>10. Cardiovascular disease and risk management: standards of care in Diabetes—2025. Diabetes Care. 2025;48(Supplement1):S207–38.
</cite> [<a href="https://doi.org/10.2337/dc25-S010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11635050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39651970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?10.%20Cardiovascular%20disease%20and%20risk%20management:%20standards%20of%20care%20in%20Diabetes%E2%80%942025.%20Diabetes%20Care.%202025;48(Supplement1):S207%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Perreault L, Kramer ES, Smith PC, Schmidt D, Argyropoulos C. A closer look at weight loss interventions in primary care: a systematic review and meta-analysis. Front Med. 2023;Volume 10–2023.</cite> [<a href="https://doi.org/10.3389/fmed.2023.1204849" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10701393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38076252/" class="usa-link">PubMed</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Hill B, de la Piedad Garcia X, Rathbone J, Malik Z, Holmes-Truscott E, Lawrence B, et al. Supporting healthcare professionals to reduce weight stigma. Australian J Gen Practitioners. 2024;53:682–5.</cite> [<a href="https://doi.org/10.31128/AJGP-07-23-6906" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39226608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hill%20B,%20de%20la%20Piedad%20Garcia%20X,%20Rathbone%20J,%20Malik%20Z,%20Holmes-Truscott%20E,%20Lawrence%20B,%20et%20al.%20Supporting%20healthcare%20professionals%20to%20reduce%20weight%20stigma.%20Australian%20J%20Gen%20Practitioners.%202024;53:682%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Emílio-Silva MT, Rodrigues VP, Fioravanti MM, Ruiz-Malagon AJ, Naia Fioretto M, Raimundo PR et al. Citral protects against metabolic endotoxemia, and systemic disorders caused by high-fat diet-induced obesity via intestinal modulation. Front Pharmacol. 2025;Volume 16–2025.</cite> [<a href="https://doi.org/10.3389/fphar.2025.1567217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12009827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40260376/" class="usa-link">PubMed</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Galan-Lopez P, Sanchez-Oliver AJ, Pihu M, Gísladóttír T, Domínguez R, Ries F. Association between adherence to the mediterranean diet and physical fitness with body composition parameters in 1717 European adolescents: the adoleshealth study. Nutrients. 2019;12(1):77.
</cite> [<a href="https://doi.org/10.3390/nu12010077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7019378/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31892139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Galan-Lopez%20P,%20Sanchez-Oliver%20AJ,%20Pihu%20M,%20G%C3%ADslad%C3%B3tt%C3%ADr%20T,%20Dom%C3%ADnguez%20R,%20Ries%20F.%20Association%20between%20adherence%20to%20the%20mediterranean%20diet%20and%20physical%20fitness%20with%20body%20composition%20parameters%20in%201717%20European%20adolescents:%20the%20adoleshealth%20study.%20Nutrients.%202019;12(1):77." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Malihi Z, Portch R, Hashemi L, Schlichting D, Wake M, Morton S, et al. Modifiable early childhood risk factors for obesity at age four years. Child Obes. 2021;17(3):196–208.
</cite> [<a href="https://doi.org/10.1089/chi.2020.0174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33595354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Malihi%20Z,%20Portch%20R,%20Hashemi%20L,%20Schlichting%20D,%20Wake%20M,%20Morton%20S,%20et%20al.%20Modifiable%20early%20childhood%20risk%20factors%20for%20obesity%20at%20age%20four%20years.%20Child%20Obes.%202021;17(3):196%E2%80%93208." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Sui X, LaMonte MJ, Laditka JN, Hardin JW, Chase N, Hooker SP, et al. Cardiorespiratory fitness and adiposity as mortality predictors in older adults. JAMA. 2007;298(21):2507–16.
</cite> [<a href="https://doi.org/10.1001/jama.298.21.2507" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2692959/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18056904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sui%20X,%20LaMonte%20MJ,%20Laditka%20JN,%20Hardin%20JW,%20Chase%20N,%20Hooker%20SP,%20et%20al.%20Cardiorespiratory%20fitness%20and%20adiposity%20as%20mortality%20predictors%20in%20older%20adults.%20JAMA.%202007;298(21):2507%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Tomlinson D, Erskine R, Morse C, Winwood K, Onambélé-Pearson G. The impact of obesity on skeletal muscle strength and structure through adolescence to old age. Biogerontology. 2016;17:467–83.
</cite> [<a href="https://doi.org/10.1007/s10522-015-9626-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4889641/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26667010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tomlinson%20D,%20Erskine%20R,%20Morse%20C,%20Winwood%20K,%20Onamb%C3%A9l%C3%A9-Pearson%20G.%20The%20impact%20of%20obesity%20on%20skeletal%20muscle%20strength%20and%20structure%20through%20adolescence%20to%20old%20age.%20Biogerontology.%202016;17:467%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>van Baak MA, Pramono A, Battista F, Beaulieu K, Blundell JE, Busetto L, et al. Effect of different types of regular exercise on physical fitness in adults with overweight or obesity: systematic review and meta-analyses. Obes Rev. 2021;22:e13239.
</cite> [<a href="https://doi.org/10.1111/obr.13239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8365680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33939229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Baak%20MA,%20Pramono%20A,%20Battista%20F,%20Beaulieu%20K,%20Blundell%20JE,%20Busetto%20L,%20et%20al.%20Effect%20of%20different%20types%20of%20regular%20exercise%20on%20physical%20fitness%20in%20adults%20with%20overweight%20or%20obesity:%20systematic%20review%20and%20meta-analyses.%20Obes%20Rev.%202021;22:e13239." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Brellenthin AG, Lee D-c, Bennie JA, Sui X, Blair SN. Resistance exercise, alone and in combination with aerobic exercise, and obesity in dallas, texas, US: A prospective cohort study. PLoS Med. 2021;18(6):e1003687.
</cite> [<a href="https://doi.org/10.1371/journal.pmed.1003687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8266085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34161329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brellenthin%20AG,%20Lee%20D-c,%20Bennie%20JA,%20Sui%20X,%20Blair%20SN.%20Resistance%20exercise,%20alone%20and%20in%20combination%20with%20aerobic%20exercise,%20and%20obesity%20in%20dallas,%20texas,%20US:%20A%20prospective%20cohort%20study.%20PLoS%20Med.%202021;18(6):e1003687." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Williamson DA, Perrin LA. Behavioral therapy for obesity. Endocrinol Metab Clin North Am. 1996;25(4):943–54.
</cite> [<a href="https://doi.org/10.1016/s0889-8529(05)70363-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8977054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Williamson%20DA,%20Perrin%20LA.%20Behavioral%20therapy%20for%20obesity.%20Endocrinol%20Metab%20Clin%20North%20Am.%201996;25(4):943%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Chao AM, Moore M, Wadden TA. The past, present, and future of behavioral obesity treatment. Int J Obes. 2024:1–10.</cite> [<a href="https://doi.org/10.1038/s41366-024-01525-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11729970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38678143/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Wilson GT, Wilfley DE, Agras WS, Bryson SW. Psychological treatments of binge eating disorder. Arch Gen Psychiatry. 2010;67(1):94–101.
</cite> [<a href="https://doi.org/10.1001/archgenpsychiatry.2009.170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3757519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20048227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilson%20GT,%20Wilfley%20DE,%20Agras%20WS,%20Bryson%20SW.%20Psychological%20treatments%20of%20binge%20eating%20disorder.%20Arch%20Gen%20Psychiatry.%202010;67(1):94%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Cha J-Y, Kim S-Y, Lim Y-W, Choi K-H, Shin I-S. Comparative effectiveness of cognitive behavioral therapy and behavioral therapy in obesity: A systematic review and network Meta-Analysis. J Clin Psychol Med Settings. 2024:1–15.</cite> [<a href="https://doi.org/10.1007/s10880-023-10000-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38285378/" class="usa-link">PubMed</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Munsch S, Biedert E, Meyer A, Michael T, Schlup B, Tuch A, et al. A randomized comparison of cognitive behavioral therapy and behavioral weight loss treatment for overweight individuals with binge eating disorder. Int J Eat Disord. 2007;40(2):102–13.
</cite> [<a href="https://doi.org/10.1002/eat.20350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17089420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Munsch%20S,%20Biedert%20E,%20Meyer%20A,%20Michael%20T,%20Schlup%20B,%20Tuch%20A,%20et%20al.%20A%20randomized%20comparison%20of%20cognitive%20behavioral%20therapy%20and%20behavioral%20weight%20loss%20treatment%20for%20overweight%20individuals%20with%20binge%20eating%20disorder.%20Int%20J%20Eat%20Disord.%202007;40(2):102%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Fossati M, Amati F, Painot D, Reiner M, Haenni C, Golay A. Cognitive-behavioral therapy with simultaneous nutritional and physical activity education in obese patients with binge eating disorder. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity. 2004;9:134-8.</cite> [<a href="https://doi.org/10.1007/BF03325057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15330081/" class="usa-link">PubMed</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Grilo CM, Masheb RM, Wilson GT. Efficacy of cognitive behavioral therapy and Fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. Biol Psychiatry. 2005;57(3):301–9.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2004.11.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15691532/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grilo%20CM,%20Masheb%20RM,%20Wilson%20GT.%20Efficacy%20of%20cognitive%20behavioral%20therapy%20and%20Fluoxetine%20for%20the%20treatment%20of%20binge%20eating%20disorder:%20a%20randomized%20double-blind%20placebo-controlled%20comparison.%20Biol%20Psychiatry.%202005;57(3):301%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Wilson GT, Grilo CM, Vitousek KM. Psychological treatment of eating disorders. Am Psychol. 2007;62(3):199.
</cite> [<a href="https://doi.org/10.1037/0003-066X.62.3.199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17469898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilson%20GT,%20Grilo%20CM,%20Vitousek%20KM.%20Psychological%20treatment%20of%20eating%20disorders.%20Am%20Psychol.%202007;62(3):199." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Fandiño J, Moreira RO, Preissler C, Gaya CW, Papelbaum M, Coutinho WF, et al. Impact of binge eating disorder in the psychopathological profile of obese women. Compr Psychiatr. 2010;51(2):110–4.</cite> [<a href="https://doi.org/10.1016/j.comppsych.2009.03.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20152289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fandi%C3%B1o%20J,%20Moreira%20RO,%20Preissler%20C,%20Gaya%20CW,%20Papelbaum%20M,%20Coutinho%20WF,%20et%20al.%20Impact%20of%20binge%20eating%20disorder%20in%20the%20psychopathological%20profile%20of%20obese%20women.%20Compr%20Psychiatr.%202010;51(2):110%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Bulik CM, Reichborn-Kjennerud T. Medical morbidity in binge eating disorder. Int J Eat Disord. 2003;34(S1):S39–46.
</cite> [<a href="https://doi.org/10.1002/eat.10204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12900985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bulik%20CM,%20Reichborn-Kjennerud%20T.%20Medical%20morbidity%20in%20binge%20eating%20disorder.%20Int%20J%20Eat%20Disord.%202003;34(S1):S39%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Vanderlinden J, Adriaensen A, Vancampfort D, Pieters G, Probst M, Vansteelandt K. A cognitive-behavioral therapeutic program for patients with obesity and binge eating disorder: short-and long-term follow-up data of a prospective study. Behav Modif. 2012;36(5):670–86.
</cite> [<a href="https://doi.org/10.1177/0145445512439313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22544460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vanderlinden%20J,%20Adriaensen%20A,%20Vancampfort%20D,%20Pieters%20G,%20Probst%20M,%20Vansteelandt%20K.%20A%20cognitive-behavioral%20therapeutic%20program%20for%20patients%20with%20obesity%20and%20binge%20eating%20disorder:%20short-and%20long-term%20follow-up%20data%20of%20a%20prospective%20study.%20Behav%20Modif.%202012;36(5):670%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Castelnuovo G, Pietrabissa G, Manzoni GM, Cattivelli R, Rossi A, Novelli M, et al. Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives. Psychol Res Behav Manag. 2017;10:165–73.
</cite> [<a href="https://doi.org/10.2147/PRBM.S113278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5476722/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28652832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Castelnuovo%20G,%20Pietrabissa%20G,%20Manzoni%20GM,%20Cattivelli%20R,%20Rossi%20A,%20Novelli%20M,%20et%20al.%20Cognitive%20behavioral%20therapy%20to%20aid%20weight%20loss%20in%20obese%20patients:%20current%20perspectives.%20Psychol%20Res%20Behav%20Manag.%202017;10:165%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Agras WS, Bohon C. Cognitive behavioral therapy for the eating disorders. Ann Rev Clin Psychol. 2021;17(1):417–38.
</cite> [<a href="https://doi.org/10.1146/annurev-clinpsy-081219-110907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33962536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Agras%20WS,%20Bohon%20C.%20Cognitive%20behavioral%20therapy%20for%20the%20eating%20disorders.%20Ann%20Rev%20Clin%20Psychol.%202021;17(1):417%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Dalle Grave R, Centis E, Marzocchi R, El Ghoch M, Marchesini G. Major factors for facilitating change in behavioral strategies to reduce obesity. Psychol Res Behav Manag. 2013;6:101–10.
</cite> [<a href="https://doi.org/10.2147/PRBM.S40460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3794892/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24124398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dalle%20Grave%20R,%20Centis%20E,%20Marzocchi%20R,%20El%20Ghoch%20M,%20Marchesini%20G.%20Major%20factors%20for%20facilitating%20change%20in%20behavioral%20strategies%20to%20reduce%20obesity.%20Psychol%20Res%20Behav%20Manag.%202013;6:101%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Browne NE, Newton AS, Gokiert R, Holt NL, Gehring ND, Perez A, et al. The application and reporting of motivational interviewing in managing adolescent obesity: A scoping review and stakeholder consultation. Obes Rev. 2022;23(11):e13505.
</cite> [<a href="https://doi.org/10.1111/obr.13505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36183740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Browne%20NE,%20Newton%20AS,%20Gokiert%20R,%20Holt%20NL,%20Gehring%20ND,%20Perez%20A,%20et%20al.%20The%20application%20and%20reporting%20of%20motivational%20interviewing%20in%20managing%20adolescent%20obesity:%20A%20scoping%20review%20and%20stakeholder%20consultation.%20Obes%20Rev.%202022;23(11):e13505." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Amiri P, Mansouri-Tehrani MM, Khalili-Chelik A, Karimi M, Jalali-Farahani S, Amouzegar A et al. Does motivational interviewing improve the weight management process in adolescents? A systematic review and meta-analysis. Int J Behav Med. 2022:1–26.</cite> [<a href="https://doi.org/10.1007/s12529-021-09994-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34268708/" class="usa-link">PubMed</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Zhu S, Sinha D, Kirk M, Michalopoulou M, Hajizadeh A, Wren G et al. Effectiveness of behavioural interventions with motivational interviewing on physical activity outcomes in adults: systematic review and meta-analysis. BMJ. 2024;386.</cite> [<a href="https://doi.org/10.1136/bmj-2023-078713" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11234249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38986547/" class="usa-link">PubMed</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Laroche HH, Andino J, O’Shea AM, Engebretsen B, Rice S, DeJear M Jr et al. Family-Based motivational interviewing and resource mobilization to prevent obesity: living well together trial. J Nutr Educ Behav. 2024.</cite> [<a href="https://doi.org/10.1016/j.jneb.2024.05.227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11381176/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38904597/" class="usa-link">PubMed</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Gudzune KA, Kushner RF. Medications for obesity: A review. JAMA. 2024;332(7):571–84.
</cite> [<a href="https://doi.org/10.1001/jama.2024.10816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39037780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gudzune%20KA,%20Kushner%20RF.%20Medications%20for%20obesity:%20A%20review.%20JAMA.%202024;332(7):571%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Pulipati VP, Pannain S. Pharmacotherapy of obesity in complex diseases. Clin Obes. 2022;12(1):e12497.
</cite> [<a href="https://doi.org/10.1111/cob.12497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34889046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pulipati%20VP,%20Pannain%20S.%20Pharmacotherapy%20of%20obesity%20in%20complex%20diseases.%20Clin%20Obes.%202022;12(1):e12497." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Caruso I, Di Gioia L, Di Molfetta S, Caporusso M, Cignarelli A, Sorice GP, et al. The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database. J Endocrinol Invest. 2024;47(11):2671–8.
</cite> [<a href="https://doi.org/10.1007/s40618-024-02441-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11473560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39141075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Caruso%20I,%20Di%20Gioia%20L,%20Di%20Molfetta%20S,%20Caporusso%20M,%20Cignarelli%20A,%20Sorice%20GP,%20et%20al.%20The%20real-world%20safety%20profile%20of%20tirzepatide:%20pharmacovigilance%20analysis%20of%20the%20FDA%20adverse%20event%20reporting%20system%20(FAERS)%20database.%20J%20Endocrinol%20Invest.%202024;47(11):2671%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Cesaro A, De Michele G, Fimiani F, Acerbo V, Scherillo G, Signore G, et al. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. Front Cardiovasc Med. 2023;10:1187735.
</cite> [<a href="https://doi.org/10.3389/fcvm.2023.1187735" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10421666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37576108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cesaro%20A,%20De%20Michele%20G,%20Fimiani%20F,%20Acerbo%20V,%20Scherillo%20G,%20Signore%20G,%20et%20al.%20Visceral%20adipose%20tissue%20and%20residual%20cardiovascular%20risk:%20a%20pathological%20link%20and%20new%20therapeutic%20options.%20Front%20Cardiovasc%20Med.%202023;10:1187735." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–8.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(18)30107-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29680205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tomson%20T,%20Battino%20D,%20Bonizzoni%20E,%20Craig%20J,%20Lindhout%20D,%20Perucca%20E,%20et%20al.%20Comparative%20risk%20of%20major%20congenital%20malformations%20with%20eight%20different%20antiepileptic%20drugs:%20a%20prospective%20cohort%20study%20of%20the%20EURAP%20registry.%20Lancet%20Neurol.%202018;17(6):530%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, et al. Managing the Gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134(1):14–9.
</cite> [<a href="https://doi.org/10.1080/00325481.2021.2002616" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34775881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wharton%20S,%20Davies%20M,%20Dicker%20D,%20Lingvay%20I,%20Mosenzon%20O,%20Rubino%20DM,%20et%20al.%20Managing%20the%20Gastrointestinal%20side%20effects%20of%20GLP-1%20receptor%20agonists%20in%20obesity:%20recommendations%20for%20clinical%20practice.%20Postgrad%20Med.%202022;134(1):14%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Manitpisitkul P, Curtin CR, Shalayda K, Wang SS, Ford L, Heald DL. Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment. Epilepsy Res. 2014;108(5):891–901.
</cite> [<a href="https://doi.org/10.1016/j.eplepsyres.2014.03.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24725807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Manitpisitkul%20P,%20Curtin%20CR,%20Shalayda%20K,%20Wang%20SS,%20Ford%20L,%20Heald%20DL.%20Pharmacokinetics%20of%20topiramate%20in%20patients%20with%20renal%20impairment,%20end-stage%20renal%20disease%20undergoing%20hemodialysis,%20or%20hepatic%20impairment.%20Epilepsy%20Res.%202014;108(5):891%E2%80%93901." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Patel ML, Wakayama LN, Bennett GG. Self-monitoring via digital health in weight loss interventions: a systematic review among adults with overweight or obesity. Obesity. 2021;29(3):478–99.
</cite> [<a href="https://doi.org/10.1002/oby.23088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33624440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20ML,%20Wakayama%20LN,%20Bennett%20GG.%20Self-monitoring%20via%20digital%20health%20in%20weight%20loss%20interventions:%20a%20systematic%20review%20among%20adults%20with%20overweight%20or%20obesity.%20Obesity.%202021;29(3):478%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>König LM, Western MJ, Denton AH, Krukowski RA. Umbrella review of social inequality in digital interventions targeting dietary and physical activity behaviors. Npj Digit Med. 2025;8(1):11.
</cite> [<a href="https://doi.org/10.1038/s41746-024-01405-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11704356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39762352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?K%C3%B6nig%20LM,%20Western%20MJ,%20Denton%20AH,%20Krukowski%20RA.%20Umbrella%20review%20of%20social%20inequality%20in%20digital%20interventions%20targeting%20dietary%20and%20physical%20activity%20behaviors.%20Npj%20Digit%20Med.%202025;8(1):11." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Wang D, Benito PJ, Rubio-Arias JÁ, Ramos‐Campo DJ, Rojo‐Tirado MA. Exploring factors of adherence to weight loss interventions in population with overweight/obesity: an umbrella review. Obes Rev. 2024:e13783.</cite> [<a href="https://doi.org/10.1111/obr.13783" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38807509/" class="usa-link">PubMed</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Pennings N, Varney C, Hines S, Riley B, Happel P, Patel S, et al. Obesity management in primary care: A joint clinical perspective and expert review from the obesity medicine association (OMA) and the American college of osteopathic family physicians (ACOFP) – 2025. Obes Pillars. 2025;14:100172.
</cite> [<a href="https://doi.org/10.1016/j.obpill.2025.100172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11997402/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40235850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pennings%20N,%20Varney%20C,%20Hines%20S,%20Riley%20B,%20Happel%20P,%20Patel%20S,%20et%20al.%20Obesity%20management%20in%20primary%20care:%20A%20joint%20clinical%20perspective%20and%20expert%20review%20from%20the%20obesity%20medicine%20association%20(OMA)%20and%20the%20American%20college%20of%20osteopathic%20family%20physicians%20(ACOFP)%20%E2%80%93%E2%80%892025.%20Obes%20Pillars.%202025;14:100172." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Bansal AB, Patel P, Al Khalili Y. Orlistat. StatPearls. Treasure Island (FL): StatPearls publishing copyright © 2025. StatPearls Publishing LLC.; 2025.</cite>
</li>
<li id="CR55">
<span class="label">55.</span><cite>Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1411892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26132939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pi-Sunyer%20X,%20Astrup%20A,%20Fujioka%20K,%20Greenway%20F,%20Halpern%20A,%20Krempf%20M,%20et%20al.%20A%20randomized,%20controlled%20trial%20of%203.0%C2%A0mg%20of%20liraglutide%20in%20weight%20management.%20N%20Engl%20J%20Med.%202015;373(1):11%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Maselli D, Atieh J, Clark MM, Eckert D, Taylor A, Carlson P, et al. Effects of liraglutide on Gastrointestinal functions and weight in obesity: A randomized clinical and Pharmacogenomic trial. Obes (Silver Spring). 2022;30(8):1608–20.</cite> [<a href="https://doi.org/10.1002/oby.23481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9335902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35894080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maselli%20D,%20Atieh%20J,%20Clark%20MM,%20Eckert%20D,%20Taylor%20A,%20Carlson%20P,%20et%20al.%20Effects%20of%20liraglutide%20on%20Gastrointestinal%20functions%20and%20weight%20in%20obesity:%20A%20randomized%20clinical%20and%20Pharmacogenomic%20trial.%20Obes%20(Silver%20Spring).%202022;30(8):1608%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Collins L, Costello RA. Glucagon-Like Peptide-1 receptor agonists. StatPearls. Treasure Island (FL): StatPearls publishing copyright © 2025. StatPearls Publishing LLC.; 2025.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/31855395/" class="usa-link">PubMed</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2032183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33567185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilding%20JPH,%20Batterham%20RL,%20Calanna%20S,%20Davies%20M,%20Van%20Gaal%20LF,%20Lingvay%20I,%20et%20al.%20Once-Weekly%20semaglutide%20in%20adults%20with%20overweight%20or%20obesity.%20N%20Engl%20J%20Med.%202021;384(11):989%E2%80%931002." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297–308.
</cite> [<a href="https://doi.org/10.3945/ajcn.111.024927" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3260065/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22158731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garvey%20WT,%20Ryan%20DH,%20Look%20M,%20Gadde%20KM,%20Allison%20DB,%20Peterson%20CA,%20et%20al.%20Two-year%20sustained%20weight%20loss%20and%20metabolic%20benefits%20with%20controlled-release%20phentermine/topiramate%20in%20obese%20and%20overweight%20adults%20(SEQUEL):%20a%20randomized,%20placebo-controlled,%20phase%203%20extension%20study.%20Am%20J%20Clin%20Nutr.%202012;95(2):297%E2%80%93308." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503–15.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2107519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34170647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fr%C3%ADas%20JP,%20Davies%20MJ,%20Rosenstock%20J,%20P%C3%A9rez%20Manghi%20FC,%20Fern%C3%A1ndez%20Land%C3%B3%20L,%20Bergman%20BK,%20et%20al.%20Tirzepatide%20versus%20semaglutide%20once%20weekly%20in%20patients%20with%20type%202%20diabetes.%20N%20Engl%20J%20Med.%202021;385(6):503%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. Effect of Naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(10)60888-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20673995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Greenway%20FL,%20Fujioka%20K,%20Plodkowski%20RA,%20Mudaliar%20S,%20Guttadauria%20M,%20Erickson%20J,%20et%20al.%20Effect%20of%20Naltrexone%20plus%20bupropion%20on%20weight%20loss%20in%20overweight%20and%20obese%20adults%20(COR-I):%20a%20multicentre,%20randomised,%20double-blind,%20placebo-controlled,%20phase%203%20trial.%20Lancet.%202010;376(9741):595%E2%80%93605." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O’Neil PM, et al. Weight loss with Naltrexone sr/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obes (Silver Spring). 2011;19(1):110–20.</cite> [<a href="https://doi.org/10.1038/oby.2010.147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4459776/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20559296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wadden%20TA,%20Foreyt%20JP,%20Foster%20GD,%20Hill%20JO,%20Klein%20S,%20O%E2%80%99Neil%20PM,%20et%20al.%20Weight%20loss%20with%20Naltrexone%20sr/bupropion%20SR%20combination%20therapy%20as%20an%20adjunct%20to%20behavior%20modification:%20the%20COR-BMOD%20trial.%20Obes%20(Silver%20Spring).%202011;19(1):110%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, et al. A randomized, phase 3 trial of Naltrexone sr/bupropion SR on weight and obesity-related risk factors (COR-II). Obes (Silver Spring). 2013;21(5):935–43.</cite> [<a href="https://doi.org/10.1002/oby.20309" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3739931/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23408728/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Apovian%20CM,%20Aronne%20L,%20Rubino%20D,%20Still%20C,%20Wyatt%20H,%20Burns%20C,%20et%20al.%20A%20randomized,%20phase%203%20trial%20of%20Naltrexone%20sr/bupropion%20SR%20on%20weight%20and%20obesity-related%20risk%20factors%20(COR-II).%20Obes%20(Silver%20Spring).%202013;21(5):935%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Hollander P, Gupta AK, Plodkowski R, Greenway F, Bays H, Burns C, et al. Effects of Naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022–9.
</cite> [<a href="https://doi.org/10.2337/dc13-0234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3836105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24144653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hollander%20P,%20Gupta%20AK,%20Plodkowski%20R,%20Greenway%20F,%20Bays%20H,%20Burns%20C,%20et%20al.%20Effects%20of%20Naltrexone%20sustained-release/bupropion%20sustained-release%20combination%20therapy%20on%20body%20weight%20and%20glycemic%20parameters%20in%20overweight%20and%20obese%20patients%20with%20type%202%20diabetes.%20Diabetes%20Care.%202013;36(12):4022%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Grilo CM, Lydecker JA, Fineberg SK, Moreno JO, Ivezaj V, Gueorguieva R. Naltrexone-Bupropion and behavior therapy, alone and combined, for Binge-Eating disorder: randomized Double-Blind Placebo-Controlled trial. Am J Psychiatry. 2022;179(12):927–37.
</cite> [<a href="https://doi.org/10.1176/appi.ajp.20220267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9722598/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36285406/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grilo%20CM,%20Lydecker%20JA,%20Fineberg%20SK,%20Moreno%20JO,%20Ivezaj%20V,%20Gueorguieva%20R.%20Naltrexone-Bupropion%20and%20behavior%20therapy,%20alone%20and%20combined,%20for%20Binge-Eating%20disorder:%20randomized%20Double-Blind%20Placebo-Controlled%20trial.%20Am%20J%20Psychiatry.%202022;179(12):927%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obes (Silver Spring). 2012;20(2):330–42.</cite> [<a href="https://doi.org/10.1038/oby.2011.330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3270297/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22051941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Allison%20DB,%20Gadde%20KM,%20Garvey%20WT,%20Peterson%20CA,%20Schwiers%20ML,%20Najarian%20T,%20et%20al.%20Controlled-release%20phentermine/topiramate%20in%20severely%20obese%20adults:%20a%20randomized%20controlled%20trial%20(EQUIP).%20Obes%20(Silver%20Spring).%202012;20(2):330%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Garvey WT. Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management. Expert Opin Drug Saf. 2013;12(5):741–56.
</cite> [<a href="https://doi.org/10.1517/14740338.2013.806481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3786546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23738843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garvey%20WT.%20Phentermine%20and%20topiramate%20extended-release:%20a%20new%20treatment%20for%20obesity%20and%20its%20role%20in%20a%20complications-centric%20approach%20to%20obesity%20medical%20management.%20Expert%20Opin%20Drug%20Saf.%202013;12(5):741%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Shin JH, Gadde KM. Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity. Diabetes Metab Syndr Obes. 2013;6:131–9.
</cite> [<a href="https://doi.org/10.2147/DMSO.S43403" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3626409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23630428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shin%20JH,%20Gadde%20KM.%20Clinical%20utility%20of%20phentermine/topiramate%20(Qsymia%E2%84%A2)%20combination%20for%20the%20treatment%20of%20obesity.%20Diabetes%20Metab%20Syndr%20Obes.%202013;6:131%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Lei XG, Ruan JQ, Lai C, Sun Z, Yang X. Efficacy and safety of phentermine/topiramate in adults with overweight or obesity: A systematic review and Meta-Analysis. Obes (Silver Spring). 2021;29(6):985–94.</cite> [<a href="https://doi.org/10.1002/oby.23152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33864346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lei%20XG,%20Ruan%20JQ,%20Lai%20C,%20Sun%20Z,%20Yang%20X.%20Efficacy%20and%20safety%20of%20phentermine/topiramate%20in%20adults%20with%20overweight%20or%20obesity:%20A%20systematic%20review%20and%20Meta-Analysis.%20Obes%20(Silver%20Spring).%202021;29(6):985%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, et al. Daily oral GLP-1 receptor agonist Orforglipron for adults with obesity. N Engl J Med. 2023;389(10):877–88.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2302392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37351564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wharton%20S,%20Blevins%20T,%20Connery%20L,%20Rosenstock%20J,%20Raha%20S,%20Liu%20R,%20et%20al.%20Daily%20oral%20GLP-1%20receptor%20agonist%20Orforglipron%20for%20adults%20with%20obesity.%20N%20Engl%20J%20Med.%202023;389(10):877%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Dutta D, Nagendra L, Anne B, Kumar M, Sharma M, Kamrul-Hasan ABM. Orforglipron, a novel non-peptide oral daily glucagon-like peptide-1 receptor agonist as an anti-obesity medicine: A systematic review and meta-analysis. Obes Sci Pract. 2024;10(2):e743.
</cite> [<a href="https://doi.org/10.1002/osp4.743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10896246/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38414573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dutta%20D,%20Nagendra%20L,%20Anne%20B,%20Kumar%20M,%20Sharma%20M,%20Kamrul-Hasan%20ABM.%20Orforglipron,%20a%20novel%20non-peptide%20oral%20daily%20glucagon-like%20peptide-1%20receptor%20agonist%20as%20an%20anti-obesity%20medicine:%20A%20systematic%20review%20and%20meta-analysis.%20Obes%20Sci%20Pract.%202024;10(2):e743." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, et al. Triple-Hormone-Receptor agonist Retatrutide for Obesity - A phase 2 trial. N Engl J Med. 2023;389(6):514–26.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2301972" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37366315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jastreboff%20AM,%20Kaplan%20LM,%20Fr%C3%ADas%20JP,%20Wu%20Q,%20Du%20Y,%20Gurbuz%20S,%20et%20al.%20Triple-Hormone-Receptor%20agonist%20Retatrutide%20for%20Obesity%20-%20A%20phase%202%20trial.%20N%20Engl%20J%20Med.%202023;389(6):514%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Pasqualotto E, Ferreira ROM, Chavez MP, Hohl A, Ronsoni MF, Pasqualotto T, et al. Effects of once-weekly subcutaneous Retatrutide on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials. Metabolism Open. 2024;24:100321.
</cite> [<a href="https://doi.org/10.1016/j.metop.2024.100321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11420505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39318607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pasqualotto%20E,%20Ferreira%20ROM,%20Chavez%20MP,%20Hohl%20A,%20Ronsoni%20MF,%20Pasqualotto%20T,%20et%20al.%20Effects%20of%20once-weekly%20subcutaneous%20Retatrutide%20on%20weight%20and%20metabolic%20markers:%20A%20systematic%20review%20and%20meta-analysis%20of%20randomized%20controlled%20trials.%20Metabolism%20Open.%202024;24:100321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, et al. Efficacy and safety of co-administered once-weekly Cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023;402(10403):720–30.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(23)01163-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37364590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Frias%20JP,%20Deenadayalan%20S,%20Erichsen%20L,%20Knop%20FK,%20Lingvay%20I,%20Macura%20S,%20et%20al.%20Efficacy%20and%20safety%20of%20co-administered%20once-weekly%20Cagrilintide%202%C2%B74%C2%A0mg%20with%20once-weekly%20semaglutide%202%C2%B74%C2%A0mg%20in%20type%202%20diabetes:%20a%20multicentre,%20randomised,%20double-blind,%20active-controlled,%20phase%202%20trial.%20Lancet.%202023;402(10403):720%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, et al. Once-weekly Cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet. 2021;398(10317):2160–72.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)01751-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34798060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lau%20DCW,%20Erichsen%20L,%20Francisco%20AM,%20Satylganova%20A,%20le%20Roux%20CW,%20McGowan%20B,%20et%20al.%20Once-weekly%20Cagrilintide%20for%20weight%20management%20in%20people%20with%20overweight%20and%20obesity:%20a%20multicentre,%20randomised,%20double-blind,%20placebo-controlled%20and%20active-controlled,%20dose-finding%20phase%202%20trial.%20Lancet.%202021;398(10317):2160%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Hartmann-Boyce J, Johns DJ, Jebb SA, Summerbell C, Aveyard P. Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis. Obes Rev. 2014;15(11):920–32.
</cite> [<a href="https://doi.org/10.1111/obr.12220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4233997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25112559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hartmann-Boyce%20J,%20Johns%20DJ,%20Jebb%20SA,%20Summerbell%20C,%20Aveyard%20P.%20Behavioural%20weight%20management%20programmes%20for%20adults%20assessed%20by%20trials%20conducted%20in%20everyday%20contexts:%20systematic%20review%20and%20meta-analysis.%20Obes%20Rev.%202014;15(11):920%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Tronieri JS, Alamuddin N, Wadden TA. Behavioral approaches to obesity management. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, et al. editors. Endotext. South Dartmouth (MA): mdtext.com, inc. Copyright © 2000–2025. MDText.com, Inc.; 2000.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/25905187/" class="usa-link">PubMed</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372397/bin/13098_2025_1925_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (14.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Diabetology &amp; Metabolic Syndrome are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13098-025-01925-z"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13098_2025_Article_1925.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (978.8 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372397/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372397/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372397%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372397/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372397/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372397/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846976/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372397/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846976/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372397/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372397/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="9iYpRuevKY5UoDz8BY24YM3oWpgewI58VThydeCXTAyoGWecHlrBqlL46EiwNli7">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
